{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T01:53:18Z","timestamp":1793843598014,"version":"4.6.1"},"reference-count":717,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Microbiol Rev"],"published-print":{"date-parts":[[2015,7]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>This comprehensive review outlines the impact of military-relevant respiratory infections, with special attention to recruit training environments, influenza pandemics in 1918 to 1919 and 2009 to 2010, and peacetime operations and conflicts in the past 25 years. Outbreaks and epidemiologic investigations of viral and bacterial infections among high-risk groups are presented, including (i) experience by recruits at training centers, (ii) impact on advanced trainees in special settings, (iii) morbidity sustained by shipboard personnel at sea, and (iv) experience of deployed personnel. Utilizing a pathogen-by-pathogen approach, we examine (i) epidemiology, (ii) impact in terms of morbidity and operational readiness, (iii) clinical presentation and outbreak potential, (iv) diagnostic modalities, (v) treatment approaches, and (vi) vaccine and other control measures. We also outline military-specific initiatives in (i) surveillance, (ii) vaccine development and policy, (iii) novel influenza and coronavirus diagnostic test development and surveillance methods, (iv) influenza virus transmission and severity prediction modeling efforts, and (v) evaluation and implementation of nonvaccine, nonpharmacologic interventions.<\/jats:p>","DOI":"10.1128\/cmr.00039-14","type":"journal-article","created":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T03:41:45Z","timestamp":1434598905000},"page":"743-800","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":94,"title":["Respiratory Infections in the U.S. Military: Recent Experience and Control"],"prefix":"10.1128","volume":"28","author":[{"given":"Jose L.","family":"Sanchez","sequence":"first","affiliation":[{"name":"Armed Forces Health Surveillance Center, Silver Spring, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Cooper","sequence":"additional","affiliation":[{"name":"Armed Forces Health Surveillance Center, Silver Spring, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Myers","sequence":"additional","affiliation":[{"name":"Naval Health Research Center, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James F.","family":"Cummings","sequence":"additional","affiliation":[{"name":"Armed Forces Health Surveillance Center, Silver Spring, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly G.","family":"Vest","sequence":"additional","affiliation":[{"name":"Armed Forces Health Surveillance Center, Silver Spring, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin L.","family":"Russell","sequence":"additional","affiliation":[{"name":"Armed Forces Health Surveillance Center, Silver Spring, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce L.","family":"Sanchez","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Division of General Internal Medicine, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle J.","family":"Hiser","sequence":"additional","affiliation":[{"name":"Armed Forces Health Surveillance Center, Silver Spring, Maryland, USA"},{"name":"Oak Ridge Institute for Science and Education, Postgraduate Research Participation Program, U.S. Army Public Health Command, Aberdeen Proving Ground, Aberdeen, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte A.","family":"Gaydos","sequence":"additional","affiliation":[{"name":"International STD, Respiratory, and Biothreat Research Laboratory, Division of Infectious Diseases, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1086\/510680"},{"key":"e_1_3_2_3_2","volume-title":"Immunizations and chemoprophylaxis for the prevention of infectious diseases","author":"Departments of the Army, Navy, Air Force, and Coast Guard","year":"2013","unstructured":"Departments of the Army, Navy, Air Force, and Coast Guard. 7 October 2013. Army Regulation 40-562, BUMED Instruction 6230.15A, Air Force Joint Instruction 48-110, Coast Guard Command Instruction M6230.4F. Immunizations and chemoprophylaxis for the prevention of infectious diseases. Departments of the Army, Navy, Air Force, and Coast Guard, Washington, DC."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0503.990308"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0749-3797(01)00323-3"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1086\/522999"},{"key":"e_1_3_2_7_2","volume-title":"Acute respiratory infections atlas","author":"Schluger N","year":"2010","unstructured":"Schluger N . 2010. Acute respiratory infections atlas, 1st ed. World Lung Foundation, New York, NY.","edition":"1"},{"key":"e_1_3_2_8_2","volume-title":"The global burden of disease: 2004 update","author":"World Health Organization","year":"2008","unstructured":"World Health Organization. 2008. The global burden of disease: 2004 update. World Health Organization, Geneva, Switzerland."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61689-4"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1201534"},{"key":"e_1_3_2_11_2","first-page":"143","article-title":"Influence of crowding on respiratory illness in a large naval training station","volume":"7","author":"Breese BB","year":"1945","unstructured":"Breese BB , Stanbury J , Upham H . 1945. Influence of crowding on respiratory illness in a large naval training station. War Med 7:143\u2013146.","journal-title":"War Med"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199108293250903"},{"key":"e_1_3_2_13_2","first-page":"227","volume-title":"Recruit medicine","author":"Russell KL","year":"2006","unstructured":"Russell KL . 2006. Respiratory infections in military recruits, p 227\u2013253. In DeKoning BL (ed), Recruit medicine. TMM Publications, Washington, DC."},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/jramc-2013-000110"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00008.2007"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.36.5.439"},{"key":"e_1_3_2_17_2","first-page":"224","article-title":"Common respiratory disease in recruits","volume":"53","author":"Sartwell PE","year":"1951","unstructured":"Sartwell PE . 1951. Common respiratory disease in recruits. Am J Hyg (Lond) 53:224\u2013235.","journal-title":"Am J Hyg (Lond)"},{"key":"e_1_3_2_18_2","first-page":"38","article-title":"Epidemiology and prevention of acute respiratory disease in naval recruits. I","volume":"55","author":"Rosenbaum MJ","year":"1965","unstructured":"Rosenbaum MJ , Edwards EA , Frank PF , Pierce WE , Crawford YE , Miller LF . 1965. Epidemiology and prevention of acute respiratory disease in naval recruits. I. Ten years' experience with microbial agents isolated from naval recruits with acute respiratory disease. Am J Public Health Nations Health 55:38\u201346.","journal-title":"Ten years' experience with microbial agents isolated from naval recruits with acute respiratory disease. Am J Public Health Nations Health"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1963.03060020052021"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-114-28680"},{"key":"e_1_3_2_21_2","first-page":"27","article-title":"Acute respiratory disease in the military","volume":"12","author":"Gray GC","year":"1995","unstructured":"Gray GC . 1995. Acute respiratory disease in the military. Fed Pract 12:27\u201333.","journal-title":"Fed Pract"},{"issue":"4","key":"e_1_3_2_22_2","first-page":"23","article-title":"Surveillance snapshot: illness and injury burdens among U.S. military recruit trainees, 2011","volume":"19","author":"Armed Forces Health Surveillance Center","year":"2012","unstructured":"Armed Forces Health Surveillance Center. 2012. Surveillance snapshot: illness and injury burdens among U.S. military recruit trainees, 2011. MSMR 19(4):23.","journal-title":"MSMR"},{"issue":"4","key":"e_1_3_2_23_2","first-page":"24","article-title":"Surveillance snapshot: illness and injury burdens among U.S. military recruit trainees, 2012","volume":"20","author":"Armed Forces Health Surveillance Center","year":"2013","unstructured":"Armed Forces Health Surveillance Center. 2013. Surveillance snapshot: illness and injury burdens among U.S. military recruit trainees, 2012. MSMR 20(4):24.","journal-title":"MSMR"},{"issue":"4","key":"e_1_3_2_24_2","first-page":"22","article-title":"Surveillance snapshot: illness and injury burdens among U.S. military recruit trainees, 2013","volume":"21","author":"Armed Forces Health Surveillance Center","year":"2014","unstructured":"Armed Forces Health Surveillance Center. 2014. Surveillance snapshot: illness and injury burdens among U.S. military recruit trainees, 2013. MSMR 21(4):22.","journal-title":"MSMR"},{"issue":"4","key":"e_1_3_2_25_2","first-page":"5","article-title":"Absolute and relative morbidity burdens attributable to various illnesses and injuries, U.S. Armed Forces, 2012","volume":"20","author":"Armed Forces Health Surveillance Center","year":"2013","unstructured":"Armed Forces Health Surveillance Center. 2013. Absolute and relative morbidity burdens attributable to various illnesses and injuries, U.S. Armed Forces, 2012. MSMR 20(4):5\u201310; discussion 8\u201310.","journal-title":"MSMR"},{"issue":"4","key":"e_1_3_2_26_2","first-page":"2","article-title":"Absolute and relative morbidity burdens attributable to various illnesses and injuries, U.S. Armed Forces, 2013","volume":"21","author":"Armed Forces Health Surveillance Center","year":"2014","unstructured":"Armed Forces Health Surveillance Center. 2014. Absolute and relative morbidity burdens attributable to various illnesses and injuries, U.S. Armed Forces, 2013. MSMR 21(4):2\u20137.","journal-title":"MSMR"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/milmed\/157.12.649"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2005.73.713"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/milmed\/158.6.392"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/milmed\/166.6.470"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.7205\/MILMED.169.10.787"},{"key":"e_1_3_2_32_2","first-page":"xv","article-title":"Upper respiratory tract infections (URI)","volume":"169","author":"Lim ML","year":"2004","unstructured":"Lim ML , Gabele SE , Wallace MR , Gray GC , Earhart KC . 2004. Upper respiratory tract infections (URI). Mil Med 169:xv\u2013xvi.","journal-title":"Mil Med"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006177"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.resp.2013.02.003"},{"key":"e_1_3_2_35_2","first-page":"6","article-title":"Position statement. Part one: immune function and exercise","volume":"17","author":"Walsh NP","year":"2011","unstructured":"Walsh NP , Gleeson M , Shephard RJ , Gleeson M , Woods JA , Bishop NC , Fleshner M , Green C , Pedersen BK , Hoffman-Goetz L , Rogers CJ , Northoff H , Abbasi A , Simon P . 2011. Position statement. Part one: immune function and exercise. Exerc Immunol Rev 17:6\u201363.","journal-title":"Exerc Immunol Rev"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.83.9.1326"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.259.14.2108"},{"key":"e_1_3_2_38_2","first-page":"125","volume-title":"Virus taxonomy: classification and nomenclature of viruses","author":"Harrach B","year":"2013","unstructured":"Harrach B , Benko M , Both GW . 2013. Family Adenoviridae, p 125\u2013141. In King AMQ , Adams MJ , Carstens EB , Lefkowitz EJ (ed), Virus taxonomy: classification and nomenclature of viruses. Ninth report of the International Committee on Taxonomy of Viruses. Academic Press, London, United Kingdom."},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(14)70831-X"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1136\/jramc-153-02-09"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-443-06839-3.00159-4"},{"key":"e_1_3_2_42_2","first-page":"1117","volume-title":"Military preventive medicine: mobilization and deployment","author":"Gray GC","year":"2005","unstructured":"Gray GC . 2005. Diseases spread by close contact: respiratory pathogens, p 1117\u20131146. In Kelley PW (ed), Military preventive medicine: mobilization and deployment, vol 2. TMM Publications, Washington, DC."},{"key":"e_1_3_2_43_2","volume-title":"Control of communicable diseases manual","author":"Heymann DL","year":"2014","unstructured":"Heymann DL . 2014. Control of communicable diseases manual, 20th ed. American Public Health Association, Washington, DC.","edition":"20"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1093\/milmed\/168.7.523"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(09)70069-6"},{"issue":"5","key":"e_1_3_2_46_2","first-page":"4","article-title":"Tuberculosis trends in the U.S. Armed Forces, active component, 1998-2012","volume":"20","author":"Mancuso JD","year":"2013","unstructured":"Mancuso JD , Aaron CL . 2013. Tuberculosis trends in the U.S. Armed Forces, active component, 1998-2012. MSMR 20(5):4\u20138.","journal-title":"MSMR"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-443-06839-3.00155-7"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-2659.2007.00029.x"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1086\/431591"},{"key":"e_1_3_2_50_2","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/B978-1-4160-4710-0.00031-6","volume-title":"Textbook of respiratory medicine","author":"Lee FE-H","year":"2010","unstructured":"Lee FE-H , Treanor J . 2010. Viral infections, p 661\u2013698. In Mason RJ , Broaddus VC , Martin TR , King TE , Schraufnagel DE , Murray JF , Nadel JA (ed), Textbook of respiratory medicine, 5th ed. Saunders Elsevier Inc, Philadelphia, PA.","edition":"5"},{"key":"e_1_3_2_51_2","first-page":"233","volume-title":"Epidemiology and prevention of vaccine-preventable diseases","author":"Pilishvili T","year":"2012","unstructured":"Pilishvili T . 2012. Pneumococcal disease, p 233\u2013246. In Atkinson W , Hamborsky J , Wolfe S (ed), Epidemiology and prevention of vaccine-preventable diseases, 12th ed. Public Health Foundation, Washington, DC.","edition":"12"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(06)70466-2"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.102.2657.561"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1086\/653083"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1086\/522970"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1086\/598520"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.21.3243"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.qco.0000216628.51563.b1"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-443-06839-3.00174-0"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20588"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-84-20714"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-85-20825"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.124.3212.119"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a121499"},{"key":"e_1_3_2_65_2","first-page":"1","article-title":"Epidemiology of acute, respiratory disease in military recruits","volume":"97","author":"Dingle JH","year":"1968","unstructured":"Dingle JH , Langmuir AD . 1968. Epidemiology of acute, respiratory disease in military recruits. Am Rev Respir Dis 97(Suppl):1\u201365.","journal-title":"Am Rev Respir Dis"},{"key":"e_1_3_2_66_2","first-page":"29","article-title":"Appraisal of occurrence of adenovirus-caused respiratory illness in military populations","volume":"66","author":"Hilleman MR","year":"1957","unstructured":"Hilleman MR , Gauld RL , Butler RL , Stallones RA , Hedberg CL , Warfield MS , Anderson SA . 1957. Appraisal of occurrence of adenovirus-caused respiratory illness in military populations. Am J Hyg (Lond) 66:29\u201341.","journal-title":"Am J Hyg (Lond)"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/140.1.48"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1086\/314498"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.2095"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1086\/342573"},{"issue":"3","key":"e_1_3_2_71_2","first-page":"9","article-title":"Adenovirus outbreak\u2014basic trainees, Fort Jackson, SC","volume":"1","author":"Barraza EM","year":"1995","unstructured":"Barraza EM . 1995. Adenovirus outbreak\u2014basic trainees, Fort Jackson, SC. MSMR 1(3):9\u201310.","journal-title":"MSMR"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1086\/314772"},{"issue":"1","key":"e_1_3_2_73_2","first-page":"8","article-title":"ARD update: adenovirus vaccine shortage","volume":"1","author":"Ludwig SL","year":"1995","unstructured":"Ludwig SL . 1995. ARD update: adenovirus vaccine shortage. MSMR 1(1):8\u20139.","journal-title":"MSMR"},{"issue":"5","key":"e_1_3_2_74_2","first-page":"14","article-title":"Incidence of acute respiratory illnesses among enlisted service members during their first year of military service: did the 2011 resumption of adenovirus vaccination of basic trainees have an effect?","volume":"20","author":"Armed Forces Health Surveillance Center","year":"2013","unstructured":"Armed Forces Health Surveillance Center. 2013. Incidence of acute respiratory illnesses among enlisted service members during their first year of military service: did the 2011 resumption of adenovirus vaccination of basic trainees have an effect? MSMR 20(5):14\u201318.","journal-title":"MSMR"},{"key":"e_1_3_2_75_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0506.990609"},{"issue":"7","key":"e_1_3_2_76_2","first-page":"12","article-title":"Adenovirus type 4 among military trainees, Fort Jackson, SC, Fort Gordon, GA","volume":"3","author":"Hendrix RM","year":"1997","unstructured":"Hendrix RM , McNeill KM . 1997. Adenovirus type 4 among military trainees, Fort Jackson, SC, Fort Gordon, GA. MSMR 3(7):12\u201313.","journal-title":"MSMR"},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0604.000419"},{"key":"e_1_3_2_78_2","doi-asserted-by":"publisher","DOI":"10.1086\/338471"},{"key":"e_1_3_2_79_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9071(199909)59:1<66::AID-JMV11>3.0.CO;2-#"},{"key":"e_1_3_2_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.12.062"},{"key":"e_1_3_2_81_2","first-page":"73","article-title":"Establishment and application of Z-HL16C cell line","volume":"14","author":"Zhao S","year":"2000","unstructured":"Zhao S , Liu Z , Xie R . 2000. Establishment and application of Z-HL16C cell line. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 14:73\u201376, 101. (In Chinese.)","journal-title":"Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi"},{"key":"e_1_3_2_82_2","first-page":"553","article-title":"Two fatal cases of adenovirus-related illness in previously healthy young adults\u2014Illinois, 2000","volume":"50","author":"Centers for Disease Control and Prevention","year":"2001","unstructured":"Centers for Disease Control and Prevention. 2001. Two fatal cases of adenovirus-related illness in previously healthy young adults\u2014Illinois, 2000. MMWR Morb Mortal Wkly Rep 50:553\u2013555.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_2_83_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1803.111238"},{"key":"e_1_3_2_84_2","volume-title":"Infectious disease as a cause of death in active duty United States military personnel, 1998-2011","author":"Potter RN","year":"2012","unstructured":"Potter RN , Seguin PG , Tremaine LA , Gaydos JC . 2012. Infectious disease as a cause of death in active duty United States military personnel, 1998-2011, abstr 1611. Abstr IDSA ID Week 2012, San Diego, CA."},{"issue":"6","key":"e_1_3_2_85_2","first-page":"2","article-title":"Adenovirus type 4 outbreak among basic trainees at Ft. Benning, Georgia, April-May 2000","volume":"6","author":"Coldren RL","year":"2000","unstructured":"Coldren RL , Feighner B , DuVernoy T , Jordan N , Gonzalez R , Alsip B . 2000. Adenovirus type 4 outbreak among basic trainees at Ft. Benning, Georgia, April-May 2000. MSMR 6(6):2\u20133.","journal-title":"MSMR"},{"key":"e_1_3_2_86_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20441"},{"key":"e_1_3_2_87_2","doi-asserted-by":"publisher","DOI":"10.1086\/592711"},{"key":"e_1_3_2_88_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01928-09"},{"key":"e_1_3_2_89_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-007-0312-6"},{"key":"e_1_3_2_90_2","doi-asserted-by":"publisher","DOI":"10.1086\/598522"},{"key":"e_1_3_2_91_2","doi-asserted-by":"publisher","DOI":"10.1086\/518442"},{"issue":"5","key":"e_1_3_2_92_2","first-page":"10","article-title":"Preliminary report: febrile acute respiratory disease caused by adenovirus type 14, U.S. Coast Guard training center, Cape May, New Jersey, March 2009","volume":"16","author":"Johns MC","year":"2009","unstructured":"Johns MC , Ludwig SL , Hawksworth A , Caldwell R , Gerding J , Renninger C , Hershberg P . 2009. Preliminary report: febrile acute respiratory disease caused by adenovirus type 14, U.S. Coast Guard training center, Cape May, New Jersey, March 2009. MSMR 16(5):10\u201311.","journal-title":"MSMR"},{"key":"e_1_3_2_93_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1605.091633"},{"key":"e_1_3_2_94_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir040"},{"key":"e_1_3_2_95_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.12.029"},{"key":"e_1_3_2_96_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1805.110865"},{"issue":"3","key":"e_1_3_2_97_2","first-page":"2","article-title":"Initial assessment of impact of adenovirus type 4 and type 7 vaccine on febrile respiratory illness and virus transmission in military basic trainees, March 2012","volume":"19","author":"Hoke CH","year":"2012","unstructured":"Hoke CH, Jr , Hawksworth A , Snyder CE, Jr . 2012. Initial assessment of impact of adenovirus type 4 and type 7 vaccine on febrile respiratory illness and virus transmission in military basic trainees, March 2012. MSMR 19(3):2\u20134.","journal-title":"MSMR"},{"issue":"3","key":"e_1_3_2_98_2","first-page":"5","article-title":"Surveillance snapshot: adenovirus among U.S. military recruit trainees","volume":"19","author":"Hawksworth A","year":"2012","unstructured":"Hawksworth A . 2012. Surveillance snapshot: adenovirus among U.S. military recruit trainees. MSMR 19(3):5.","journal-title":"MSMR"},{"key":"e_1_3_2_99_2","volume-title":"Infection cases \u2018not SARS'","author":"Juan S","year":"2012","unstructured":"Juan S , Qingyun W . 27 February 2012. Infection cases \u2018not SARS'. China Daily Newspaper, Beijing, China. http:\/\/www.chinadaily.com.cn\/china\/2012-02\/27\/content_14696146.htm China Daily. Accessed 23 January 2014."},{"key":"e_1_3_2_100_2","volume-title":"Chinese military hospital in lockdown over suspected SARS cases","author":"Chen M","year":"2012","unstructured":"Chen M . 27 February 2012. Chinese military hospital in lockdown over suspected SARS cases. Epoch Times, New York, NY. http:\/\/www.theepochtimes.com\/n2\/china-news\/chinese-military-hospital-in-lockdown-over-suspected-sars-cases-196361.html . Accessed 23 January 2014."},{"key":"e_1_3_2_101_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01694-09"},{"key":"e_1_3_2_102_2","doi-asserted-by":"publisher","DOI":"10.3947\/ic.2012.44.5.372"},{"key":"e_1_3_2_103_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2005.131692"},{"key":"e_1_3_2_104_2","doi-asserted-by":"publisher","DOI":"10.7883\/yoken.66.359"},{"key":"e_1_3_2_105_2","doi-asserted-by":"publisher","DOI":"10.1111\/1348-0421.12074"},{"key":"e_1_3_2_106_2","first-page":"119","article-title":"Isolation and typing of adenoviruses recovered from military recruits with acute respiratory disease in The Netherlands","volume":"65","author":"Van Der Veen J","year":"1957","unstructured":"Van Der Veen J , Kok G . 1957. Isolation and typing of adenoviruses recovered from military recruits with acute respiratory disease in The Netherlands. Am J Hyg (Lond) 65:119\u2013129.","journal-title":"Am J Hyg (Lond)"},{"key":"e_1_3_2_107_2","doi-asserted-by":"publisher","DOI":"10.1086\/522969"},{"key":"e_1_3_2_108_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu507"},{"key":"e_1_3_2_109_2","doi-asserted-by":"publisher","DOI":"10.1086\/525261"},{"key":"e_1_3_2_110_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-443-06839-3.00143-0"},{"key":"e_1_3_2_111_2","volume-title":"FDA 510(k) for Lyra adenovirus assay","author":"Food and Drug Administration","year":"2014","unstructured":"Food and Drug Administration. 9 October 2014. FDA 510(k) for Lyra adenovirus assay. Food and Drug Administration, Silver Spring, MD. http:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf14\/K141931.pdf . Accessed 12 February 2015."},{"key":"e_1_3_2_112_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.10382"},{"key":"e_1_3_2_113_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.05010-11"},{"key":"e_1_3_2_114_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2012.11.012"},{"key":"e_1_3_2_115_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cll.2014.02.011"},{"key":"e_1_3_2_116_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cll.2014.02.009"},{"key":"e_1_3_2_117_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02436-06"},{"key":"e_1_3_2_118_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01384-12"},{"key":"e_1_3_2_119_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026047"},{"key":"e_1_3_2_120_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.05996-11"},{"key":"e_1_3_2_121_2","volume-title":"Biofire FilmArray respiratory panel","author":"BioFire Diagnostics Inc","year":"2014","unstructured":"BioFire Diagnostics Inc. 2014. Biofire FilmArray respiratory panel. BioFire Diagnostics Inc, Salt Lake City, UT. http:\/\/www.biofiredx.com\/media\/InfoSheet-FilmArray-Respiratory-Panel-0229.pdf . Accessed 28 January 2015."},{"key":"e_1_3_2_122_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2009.06.008"},{"key":"e_1_3_2_123_2","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1128\/9781555816728.ch101","volume-title":"Manual of clinical microbiology","author":"Robinson C","year":"2011","unstructured":"Robinson C , Echavarria M . 2011. Adenoviruses, p 1600\u20131611. In Versalovic J , Carroll KC , Jorgensen JH , Funke G , Landry ML , Warnock DW (ed), Manual of clinical microbiology, 10th ed, vol 2. ASM Press, Washington, DC.","edition":"10"},{"key":"e_1_3_2_124_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinmicnews.2011.09.004"},{"key":"e_1_3_2_125_2","doi-asserted-by":"publisher","DOI":"10.1586\/14787210.2013.836964"},{"key":"e_1_3_2_126_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-014-0416-y"},{"key":"e_1_3_2_127_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2006.04.007"},{"key":"e_1_3_2_128_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2013.11.009"},{"key":"e_1_3_2_129_2","volume-title":"Implementation guidance for administration of adenovirus type 4 and type 7 vaccine live, oral, 12 August 2011","author":"Military Vaccine Agency, Vaccine Healthcare Centers Network","year":"2011","unstructured":"Military Vaccine Agency, Vaccine Healthcare Centers Network. 2011. Implementation guidance for administration of adenovirus type 4 and type 7 vaccine live, oral, 12 August 2011. Military Vaccine Agency, Falls Church, VA. http:\/\/www.vaccines.mil\/Adenovirus . Accessed 9 April 2014."},{"key":"e_1_3_2_130_2","volume-title":"Adenovirus type 4 and type 7 vaccine, live oral\u2014product approval information, 16 March 2011","author":"Food and Drug Administration, Center for Biologics Evaluation and Research","year":"2011","unstructured":"Food and Drug Administration, Center for Biologics Evaluation and Research. 2011. Adenovirus type 4 and type 7 vaccine, live oral\u2014product approval information, 16 March 2011. Food and Drug Administration, Silver Spring, MD. http:\/\/www.fda.gov\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/ucm247511.htm . Accessed 9 April 2014."},{"key":"e_1_3_2_131_2","volume-title":"The U.S. Army Medical Department in the World War, volume IX: communicable and other diseases","author":"Siler JF","year":"1928","unstructured":"Siler JF . 1928. The U.S. Army Medical Department in the World War, volume IX: communicable and other diseases. Office of the Surgeon General, Department of the Army, Washington, DC."},{"key":"e_1_3_2_132_2","first-page":"587","article-title":"Communicable disease in the United States Army during the summer and autumn of 1918","volume":"3","author":"Vaughan VC","year":"1918","unstructured":"Vaughan VC , Palmer GT . 1918. Communicable disease in the United States Army during the summer and autumn of 1918. J Lab Clin Med 3:587\u2013623, 647\u2013686.","journal-title":"J Lab Clin Med"},{"key":"e_1_3_2_133_2","doi-asserted-by":"publisher","DOI":"10.1177\/00333549101250S311"},{"key":"e_1_3_2_134_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1919.02610020026010"},{"key":"e_1_3_2_135_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2010.07.006"},{"issue":"1","key":"e_1_3_2_136_2","first-page":"17","article-title":"Surveillance snapshot: influenza reportable events, service members and other beneficiaries, 2009-2010","volume":"17","author":"Armed Forces Health Surveillance Center","year":"2010","unstructured":"Armed Forces Health Surveillance Center. 2010. Surveillance snapshot: influenza reportable events, service members and other beneficiaries, 2009-2010. MSMR 17(1):17.","journal-title":"MSMR"},{"key":"e_1_3_2_137_2","first-page":"400","article-title":"Swine influenza A (H1N1) infection in two children\u2014Southern California, March-April 2009","volume":"58","author":"Centers for Disease Control and Prevention","year":"2009","unstructured":"Centers for Disease Control and Prevention. 2009. Swine influenza A (H1N1) infection in two children\u2014Southern California, March-April 2009. MMWR Morb Mortal Wkly Rep 58:400\u2013402.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_2_138_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0903810"},{"key":"e_1_3_2_139_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-11-S2-S3"},{"key":"e_1_3_2_140_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-2659.2012.00339.x"},{"issue":"5","key":"e_1_3_2_141_2","first-page":"17","article-title":"Surveillance snapshot: influenza A and B, service members and beneficiaries, April-May 2009","volume":"16","author":"Armed Forces Health Surveillance Center","year":"2009","unstructured":"Armed Forces Health Surveillance Center. 2009. Surveillance snapshot: influenza A and B, service members and beneficiaries, April-May 2009. MSMR 16(5):17.","journal-title":"MSMR"},{"key":"e_1_3_2_142_2","doi-asserted-by":"publisher","DOI":"10.1086\/648508"},{"key":"e_1_3_2_143_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq027"},{"key":"e_1_3_2_144_2","doi-asserted-by":"publisher","DOI":"10.1590\/S1135-57272010000500011"},{"key":"e_1_3_2_145_2","doi-asserted-by":"publisher","DOI":"10.1097\/DMP.0b013e3181bf249b"},{"issue":"9","key":"e_1_3_2_146_2","first-page":"8","article-title":"Preliminary report: outbreak of novel H1N1 influenza aboard USS Boxer, 29 June-31 July 2009","volume":"16","author":"Almond NB","year":"2009","unstructured":"Almond NB , Hollis EM , Thun AM , Clark LL , Eick AA , Sessions CK , Hinnerichs CM , Pastore LJ , Cummings JM , Daly PJ . 2009. Preliminary report: outbreak of novel H1N1 influenza aboard USS Boxer, 29 June-31 July 2009. MSMR 16(9):8\u20139.","journal-title":"MSMR"},{"key":"e_1_3_2_147_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068639"},{"key":"e_1_3_2_148_2","first-page":"162","article-title":"Outbreak of 2009 pandemic influenza A (H1N1) on a Peruvian Navy ship\u2014June-July 2009","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","unstructured":"Centers for Disease Control and Prevention. 2010. Outbreak of 2009 pandemic influenza A (H1N1) on a Peruvian Navy ship\u2014June-July 2009. MMWR Morb Mortal Wkly Rep 59:162\u2013165.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_2_149_2","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12240"},{"key":"e_1_3_2_150_2","doi-asserted-by":"publisher","DOI":"10.1086\/656480"},{"key":"e_1_3_2_151_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908482"},{"key":"e_1_3_2_152_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015933"},{"key":"e_1_3_2_153_2","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12100"},{"key":"e_1_3_2_154_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2009.10.005"},{"key":"e_1_3_2_155_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.404"},{"key":"e_1_3_2_156_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.puhe.2011.04.005"},{"key":"e_1_3_2_157_2","volume-title":"Pandemic (H1N1) 2009 virus infection in Afghanistan. Weekly epidemiological monitoring","author":"World Health Organization, Eastern Mediterranean Regional Office","year":"2009","unstructured":"World Health Organization, Eastern Mediterranean Regional Office. 2009. Pandemic (H1N1) 2009 virus infection in Afghanistan. Weekly epidemiological monitoring. World Health Organization, Geneva, Switzerland."},{"issue":"11","key":"e_1_3_2_158_2","first-page":"8","article-title":"Preliminary report: investigation of and response to novel influenza among soldiers of the Afghan National Army, Kabul, Afghanistan, 30 October-14 November 2009","volume":"16","author":"Kim PY","year":"2009","unstructured":"Kim PY , Mangham D , Hall F , Hofmeister E . 2009. Preliminary report: investigation of and response to novel influenza among soldiers of the Afghan National Army, Kabul, Afghanistan, 30 October-14 November 2009. MSMR 16(11):8\u201310.","journal-title":"MSMR"},{"key":"e_1_3_2_159_2","doi-asserted-by":"publisher","DOI":"10.2298\/VSP1306580M"},{"key":"e_1_3_2_160_2","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2011.13307"},{"key":"e_1_3_2_161_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00570-14"},{"issue":"1","key":"e_1_3_2_162_2","first-page":"7","article-title":"Influenza A(H3N2) outbreak at transit center at Manas, Kyrgyzstan, 2014","volume":"22","author":"Parms TA","year":"2015","unstructured":"Parms TA , Zorich SC , Kramer KP . 2015. Influenza A(H3N2) outbreak at transit center at Manas, Kyrgyzstan, 2014. MSMR 22(1):7\u201310.","journal-title":"MSMR"},{"issue":"9","key":"e_1_3_2_163_2","first-page":"11","article-title":"Update: pneumonia-influenza and severe acute respiratory illnesses, active component, U.S. Armed Forces, July 2000-June 2012","volume":"19","author":"Armed Forces Health Surveillance Center","year":"2012","unstructured":"Armed Forces Health Surveillance Center. 2012. Update: pneumonia-influenza and severe acute respiratory illnesses, active component, U.S. Armed Forces, July 2000-June 2012. MSMR 19(9):11\u201315.","journal-title":"MSMR"},{"key":"e_1_3_2_164_2","unstructured":"World Health Organization. 14 November 2014. Global Influenza Programme FluNet summary. World Health Organization Geneva Switzerland. http:\/\/www.who.int\/influenza\/gisrs_laboratory\/updates\/summaryreport\/en\/ . Accessed 24 November 2014."},{"key":"e_1_3_2_165_2","unstructured":"US Air Force School of Aerospace Medicine. 3 January 2015. DoD Global Laboratory-Based Influenza Surveillance Program respiratory highlights 21 December 2014-3 January 2015. US Air Force School of Aerospace Medicine Wright-Patterson Air Force Base OH."},{"key":"e_1_3_2_166_2","unstructured":"Centers for Disease Control and Prevention. 3 December 2014. Health advisory regarding the potential for circulation of drifted influenza A (H3N2) viruses. CDCHAN-00374. Centers for Disease Control and Prevention Atlanta GA. http:\/\/emergency.cdc.gov\/han\/han00374.asp . Accessed 8 December 2014."},{"key":"e_1_3_2_167_2","first-page":"1189","article-title":"Update: influenza activity\u2014United States, September 28-December 6, 2014","volume":"63","author":"Rolfes M","year":"2014","unstructured":"Rolfes M , Blanton L , Brammer L , Smith S , Mustaquim D , Steffens C , Cohen J , Leon M , Chaves SS , Abd Elal AI , Gubareva L , Hall H , Wallis T , Villanueva J , Bresee J , Cox N , Finelli L . 2014. Update: influenza activity\u2014United States, September 28-December 6, 2014. MMWR Morb Mortal Wkly Rep 63:1189\u20131194.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_2_168_2","first-page":"206","article-title":"Update: influenza activity\u2014United States, September 28, 2014-February 21, 2015","volume":"64","author":"D'Mello T","year":"2015","unstructured":"D'Mello T , Brammer L , Blanton L , Kniss K , Smith S , Mustaquim D , Steffens C , Dhara R , Cohen J , Chaves SS , Finelli L , Bresee J , Wallis T , Xu X , Abd Elal AI , Gubareva L , Wentworth D , Villanueva J , Katz J , Jernigan D . 2015. Update: influenza activity\u2014United States, September 28, 2014-February 21, 2015. MMWR Morb Mortal Wkly Rep 64:206\u2013212.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_2_169_2","unstructured":"World Health Organization. 4 December 2014. H5N1 highly pathogenic avian influenza: timeline of major events. World Health Organization Geneva Switzerland. http:\/\/who.int\/influenza\/human_animal_interface\/H5N1_avian_influenza_update20141204.pdf . Accessed 23 December 2014."},{"key":"e_1_3_2_170_2","unstructured":"World Health Organization. 1 May 2015. Influenza at the human-animal interface: summary and assessment as of 1 May 2015. World Health Organization Geneva Switzerland. http:\/\/who.int\/influenza\/human_animal_interface\/Influenza_Summary_IRA_HA_interface_1_May_2015.pdf?ua=1 . Accessed 19 May 2015."},{"key":"e_1_3_2_171_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa044021"},{"key":"e_1_3_2_172_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60493-6"},{"key":"e_1_3_2_173_2","unstructured":"Centers for Disease Control and Prevention. 8 January 2014. Highly pathogenic avian influenza A (H5N1) in people. Centers for Disease Control and Prevention Atlanta GA. http:\/\/www.cdc.gov\/flu\/avianflu\/h5n1-people.htm . Accessed 20 May 2014."},{"key":"e_1_3_2_174_2","unstructured":"World Health Organization. 31 March 2015. Influenza at the human-animal interface: monthly risk assessment summary as of 31 March 2015. World Health Organization Geneva Switzerland. http:\/\/who.int\/influenza\/human_animal_interface\/HAI_Risk_Assessment\/en\/ . Accessed 13 May 2015."},{"key":"e_1_3_2_175_2","unstructured":"Centers for Disease Control and Prevention. 24 October 2014. Influenza A (H3N2) variant virus case count: detected U.S. human infections with H3N2v by state since August 2011. Centers for Disease Control and Prevention Atlanta GA. http:\/\/www.cdc.gov\/flu\/swineflu\/h3n2v-case-count.htm . Accessed 29 January 2015."},{"key":"e_1_3_2_176_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit649"},{"key":"e_1_3_2_177_2","unstructured":"Centers for Disease Control and Prevention. 4 September 2014. Influenza A (H3N2) variant virus. Centers for Disease Control and Prevention Atlanta GA. http:\/\/www.cdc.gov\/flu\/swineflu\/h3n2v-cases.htm . Accessed 15 January 2015."},{"key":"e_1_3_2_178_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit298"},{"key":"e_1_3_2_179_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit650"},{"key":"e_1_3_2_180_2","volume-title":"Human infection with influenza A(H7N9) virus in China","author":"World Health Organization","year":"2013","unstructured":"World Health Organization. 1 April 2013. Human infection with influenza A(H7N9) virus in China. World Health Organization, Geneva, Switzerland. http:\/\/www.who.int\/csr\/don\/2013_04_01\/en\/ . Accessed 15 May 2014."},{"key":"e_1_3_2_181_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature14348"},{"key":"e_1_3_2_182_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.00140"},{"key":"e_1_3_2_183_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2104.141442"},{"key":"e_1_3_2_184_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2105.141137"},{"key":"e_1_3_2_185_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2009.140424"},{"key":"e_1_3_2_186_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1422456112"},{"key":"e_1_3_2_187_2","doi-asserted-by":"crossref","unstructured":"Yang Y Zhang Y Fang L Halloran ME Ma M Liang S Kenah E Britton T Chen E Hu J Tang F Cao W Feng Z Longini IM Jr . 2015. Household transmissibility of avian influenza A (H7N9) virus China February to May 2013 and October 2013 to March 2014. Euro Surveill 20(10):pii=21056. http:\/\/www.eurosurveillance.org\/ViewArticle.aspx?ArticleId=21056 .","DOI":"10.2807\/1560-7917.ES2015.20.10.21056"},{"key":"e_1_3_2_188_2","unstructured":"FluTrackers.com. 28 January 2015. 2013-15 human case list of provincial\/ministry of health\/government confirmed influenza A(H7N9) cases with links. FluTrackers.com Winter Park FL. https:\/\/flutrackers.com\/forum\/forum\/china-h7n9-outbreak-tracking\/143874-flutrackers-2013-15-human-case-list-of-provincial-ministry-of-health-government-confirmed-influenza-a-h7n9-cases-with-links . Accessed 28 January 2015."},{"key":"e_1_3_2_189_2","unstructured":"World Health Organization. 8 February 2015. Human infection with influenza A(H7N9) virus in China. World Health Organization Geneva Switzerland. http:\/\/who.int\/csr\/don\/8-february-2015-avian-influenza\/en\/ . Accessed 11 February 2015."},{"key":"e_1_3_2_190_2","unstructured":"World Health Organization. 26 January 2015. Risk assessment: human infections with avian influenza A(H7N9) virus. World Health Organization Geneva Switzerland. http:\/\/who.int\/influenza\/human_animal_interface\/influenza_h7n9\/en\/ . Accessed 11 February 2015."},{"key":"e_1_3_2_191_2","unstructured":"Centers for Disease Control and Prevention. 17 June 2014. New study highlights risk factors for human infection with H7N9 bird flu. Centers for Disease Control and Prevention Atlanta GA. http:\/\/www.cdc.gov\/flu\/news\/h7n9-risk-factors.htm . Accessed 28 January 2015."},{"key":"e_1_3_2_192_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5116"},{"key":"e_1_3_2_193_2","unstructured":"Centers for Disease Control and Prevention. 12 February 2014. Avian influenza A (H7N9) virus update. Centers for Disease Control and Prevention Atlanta GA. http:\/\/www.cdc.gov\/flu\/avianflu\/h7n9-virus.htm . Accessed 28 January 2015."},{"key":"e_1_3_2_194_2","unstructured":"World Health Organization. 14 July 2014. Map and epidemiological curve of confirmed human cases of avian influenza A(H7N9). World Health Organization Geneva Switzerland. http:\/\/who.int\/influenza\/human_animal_interface\/influenza_h7n9\/Data_Reports\/en\/ . Accessed 28 January 2015."},{"key":"e_1_3_2_195_2","unstructured":"World Health Organization. 23 February 2015. Risk assessment: human infections with avian influenza A(H7N9) virus. World Health Organization Geneva Switzerland. http:\/\/who.int\/influenza\/human_animal_interface\/influenza_h7n9\/RiskAssessment_H7N9_23Feb20115.pdf?ua=1 . Accessed 11 March 2015."},{"key":"e_1_3_2_196_2","unstructured":"Food and Agriculture Organization United Nations. 2014. Avian influenza A(H5N6): the latest addition to emerging zoonotic avian influenza threats in East and Southeast Asia. Food and Agriculture Organization Rome Italy. http:\/\/www.fao.org\/3\/a-i4199e.pdf . Accessed 18 March 2015."},{"key":"e_1_3_2_197_2","unstructured":"Centers for Disease Control and Prevention. 15 January 2014. Health Advisory Health Alert Network human infection with avian influenza A (H5N1) virus. Centers for Disease Control and Prevention Atlanta GA. http:\/\/emergency.cdc.gov\/HAN\/han00360.asp . Accessed 17 April 2014."},{"key":"e_1_3_2_198_2","unstructured":"World Health Organization. 2 October 2014. Risk assessment: human infections with avian influenza A(H7N9) virus. World Health Organization Geneva Switzerland. http:\/\/www.who.int\/influenza\/human_animal_interface\/influenza_h7n9\/riskassessment_h7n9_2Oct14.pdf?ua=1 . Accessed 28 October 2014."},{"key":"e_1_3_2_199_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067366"},{"key":"e_1_3_2_200_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60163-X"},{"key":"e_1_3_2_201_2","volume-title":"Influenza due to identified avian or animal influenza virus,18 December 2013, international health regulations","author":"World Health Organization","year":"2013","unstructured":"World Health Organization. 2013. Influenza due to identified avian or animal influenza virus,18 December 2013, international health regulations. World Health Organization, Geneva, Switzerland."},{"key":"e_1_3_2_202_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2012.140911"},{"key":"e_1_3_2_203_2","first-page":"373","volume-title":"Textbook of influenza","author":"Hayden FG","year":"2013","unstructured":"Hayden FG , de Jong MD . 2013. Human influenza: pathogenesis, clinical features, and management, p 373\u2013391. In Webster RG , Monto AS , Braciale TJ , Lamb RA (ed), Textbook of influenza, 2nd ed. John Wiley & Sons, Ltd, West Sussex, United Kingdom.","edition":"2"},{"key":"e_1_3_2_204_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1400034"},{"key":"e_1_3_2_205_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-2659.2012.00342.x"},{"key":"e_1_3_2_206_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.479"},{"key":"e_1_3_2_207_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ060"},{"key":"e_1_3_2_208_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1000449"},{"key":"e_1_3_2_209_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMx100025"},{"key":"e_1_3_2_210_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.2116"},{"key":"e_1_3_2_211_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-443-06839-3.00165-X"},{"key":"e_1_3_2_212_2","volume-title":"Guidance for clinicians on the use of rapid influenza diagnostic tests","author":"Centers for Disease Control and Prevention","year":"2013","unstructured":"Centers for Disease Control and Prevention. 27 August 2013. Guidance for clinicians on the use of rapid influenza diagnostic tests. Centers for Disease Control and Prevention, Atlanta, GA. http:\/\/www.cdc.gov\/flu\/professionals\/diagnosis\/clinician_guidance_ridt.htm . Accessed 29 October 2014."},{"key":"e_1_3_2_213_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-2659.2009.00086.x"},{"key":"e_1_3_2_214_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc0904264"},{"key":"e_1_3_2_215_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2010.10.009"},{"key":"e_1_3_2_216_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.03441-14"},{"key":"e_1_3_2_217_2","unstructured":"Centers for Disease Control and Prevention. 13 November 2014. Guidance for clinicians on the use of rapid influenza diagnostic tests. Centers for Disease Control and Prevention Atlanta GA. http:\/\/www.cdc.gov\/flu\/professionals\/diagnosis\/clinician_guidance_ridt.htm . Accessed 28 January 2015."},{"key":"e_1_3_2_218_2","unstructured":"Centers for Disease Control and Prevention. 16 October 2014. Guidance for clinicians on the use of RT-PCR and other molecular assays for diagnosis of influenza virus infection. Centers for Disease Control and Prevention Atlanta GA. http:\/\/www.cdc.gov\/flu\/professionals\/diagnosis\/molecular-assays.htm . Accessed 28 October 2014."},{"key":"e_1_3_2_219_2","unstructured":"Chemical Biological Medical Systems Joint Project Management Office. 10 June 2013. Fact sheet Joint Biological Agent Integrated Diagnostic System (JBAIDS). Chemical Biological Radiological & Nuclear Information Resource Center (CBRN IRC) Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD) Frederick MD. https:\/\/jacks.jpeocbd.army.mil\/Jacks\/Public\/FactSheetProvider.aspx?productId=344 . Accessed 28 January 2015."},{"key":"e_1_3_2_220_2","doi-asserted-by":"crossref","unstructured":"Russell KL Ryan MAK Hawksworth AW Freed NE Irvine M Daum LT NHRC Respiratory Disease Surveillance Team. 2005. Effectiveness of the 2003-2004 influenza vaccine among U.S. military basic trainees: a year of suboptimal match between vaccine and circulating strain. Vaccine 23:1981\u20131985. doi:10.1016\/j.vaccine.2004.10.023.","DOI":"10.1016\/j.vaccine.2004.10.023"},{"key":"e_1_3_2_221_2","unstructured":"Food and Drug Administration. 2014. Medical devices A\/H7N9 influenza rapid test\u2014letter of authorization 25 April 2014. Food and Drug Administration Silver Spring MD. http:\/\/www.fda.gov\/MedicalDevices\/Safety\/EmergencySituations\/ucm395069.htm . Accessed 5 May 2014."},{"key":"e_1_3_2_222_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir047"},{"key":"e_1_3_2_223_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir046"},{"key":"e_1_3_2_224_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013293"},{"key":"e_1_3_2_225_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000489"},{"key":"e_1_3_2_226_2","doi-asserted-by":"publisher","DOI":"10.1586\/erm.10.107"},{"key":"e_1_3_2_227_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2012.05.002"},{"key":"e_1_3_2_228_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01978-12"},{"key":"e_1_3_2_229_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01336-10"},{"key":"e_1_3_2_230_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.06520-11"},{"key":"e_1_3_2_231_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2012.07.023"},{"key":"e_1_3_2_232_2","unstructured":"Food and Drug Administration. 6 January 2015. FDA grants first CLIA waiver for nucleic acid-based flu diagnostic test. Food and Drug Administration Silver Spring MD. http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm429127.htm . Accessed 9 January 2015."},{"key":"e_1_3_2_233_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054015"},{"key":"e_1_3_2_234_2","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12288"},{"key":"e_1_3_2_235_2","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12046"},{"key":"e_1_3_2_236_2","first-page":"1","article-title":"Antiviral agents for the treatment and chemoprophylaxis of influenza\u2014recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"60","author":"Fiore AE","year":"2011","unstructured":"Fiore AE , Fry A , Shay D , Gubareva L , Bresee JS , Uyeki TM . 2011. Antiviral agents for the treatment and chemoprophylaxis of influenza\u2014recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommend Rep 60:1\u201324.","journal-title":"MMWR Recommend Rep"},{"key":"e_1_3_2_237_2","unstructured":"Centers for Disease Control and Prevention. 4 December 2014. Influenza antiviral medications: summary for clinicians. Centers for Disease Control and Prevention Atlanta GA. http:\/\/www.cdc.gov\/flu\/professionals\/antivirals\/summary-clinicians.htm . Accessed 28 January 2015."},{"key":"e_1_3_2_238_2","unstructured":"Food and Drug Administration. 22 December 2014. FDA approves Rapivab to treat flu infection. Food and Drug Administration Silver Spring MD. http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm427755.htm . Accessed 23 December 2014."},{"key":"e_1_3_2_239_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(14)70828-X"},{"key":"e_1_3_2_240_2","volume-title":"Influenza antiviral medications: summary for clinicians","author":"Centers For Disease Control and Prevention","year":"2014","unstructured":"Centers For Disease Control and Prevention. 5 February 2014. Influenza antiviral medications: summary for clinicians. Centers For Disease Control and Prevention, Atlanta, GA. http:\/\/www.cdc.gov\/flu\/professionals\/antivirals\/summary-clinicians.htm . Accessed 19 March 2014."},{"key":"e_1_3_2_241_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)62449-1"},{"key":"e_1_3_2_242_2","volume-title":"Influenza (flu) antiviral drugs and related information","author":"Food and Drug Administration","year":"2014","unstructured":"Food and Drug Administration. 22 December 2014. Influenza (flu) antiviral drugs and related information. Food and Drug Administration, Silver Spring, MD. http:\/\/www.fda.gov\/Drugs\/DrugSafety\/InformationbyDrugClass\/ucm100228.htm . Accessed 23 December 2014."},{"key":"e_1_3_2_243_2","doi-asserted-by":"publisher","DOI":"10.1086\/598513"},{"key":"e_1_3_2_244_2","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12085"},{"key":"e_1_3_2_245_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(14)70041-4"},{"key":"e_1_3_2_246_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1403496"},{"key":"e_1_3_2_247_2","doi-asserted-by":"publisher","DOI":"10.1086\/509925"},{"key":"e_1_3_2_248_2","doi-asserted-by":"publisher","DOI":"10.1086\/589748"},{"key":"e_1_3_2_249_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis726"},{"key":"e_1_3_2_250_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2014.07.001"},{"key":"e_1_3_2_251_2","unstructured":"Centers for Disease Control and Prevention. 1 December 2014. Intravenous influenza antiviral medications and CDC considerations related to investigational use of intravenous zanamivir for 2014-2015 influenza season. http:\/\/www.cdc.gov\/flu\/professionals\/antivirals\/intravenous-antivirals.htm . Accessed 23 December 2014."},{"key":"e_1_3_2_252_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(14)70821-7"},{"key":"e_1_3_2_253_2","volume-title":"Alinia prescribing information","author":"Romark Laboratories LC","year":"2011","unstructured":"Romark Laboratories LC. 2011. Alinia prescribing information. Romark Laboratories LC, Tampa, FL."},{"key":"e_1_3_2_254_2","volume-title":"Abstr 49th Infect Dis Soc Am Annu Meet, Boston, MA, 20 to 23 October 2011","author":"Belardo G","year":"2011","unstructured":"Belardo G , La Frazia S , Cenciarelli O , Carta S , Rossignol JF , Santoro MG . 2011. Nitazoxanide, a novel potential anti-influenza drug, acting in synergism with neuraminidase inhibitors, poster 1181, Abstr 49th Infect Dis Soc Am Annu Meet, Boston, MA, 20 to 23 October 2011. https:\/\/idsa.confex.com\/idsa\/2011\/webprogram\/Paper31075.html . Accessed 28 January 2015."},{"key":"e_1_3_2_255_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2014.07.014"},{"key":"e_1_3_2_256_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03947-14"},{"key":"e_1_3_2_257_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(14)70717-0"},{"key":"e_1_3_2_258_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis622"},{"key":"e_1_3_2_259_2","unstructured":"Vertex Pharmaceuticals Inc. 2014. Press release. Vertex licenses VX-787 to Janssen Pharmaceuticals for the treatment of influenza 18 June 2014. http:\/\/investors.vrtx.com\/releases.cfm?hdr02=press . Accessed 20 June 2014."},{"key":"e_1_3_2_260_2","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12293"},{"key":"e_1_3_2_261_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu396"},{"key":"e_1_3_2_262_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2010.10.003"},{"key":"e_1_3_2_263_2","doi-asserted-by":"publisher","DOI":"10.1086\/381128"},{"key":"e_1_3_2_264_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.6.748"},{"key":"e_1_3_2_265_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113633"},{"key":"e_1_3_2_266_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-013-0622-9"},{"key":"e_1_3_2_267_2","unstructured":"Immunization Healthcare Branch Public Health Division Defense Health Agency. 24 October 2013. Immunization goal for the 2013-2014 influenza season 24 October 2013. Defense Health Agency Falls Church VA. http:\/\/www.vaccines.mil\/Influenza_-_Seasonal . Accessed 9 April 2014."},{"key":"e_1_3_2_268_2","unstructured":"Military Vaccine Agency Vaccine Healthcare Centers Network. 2008. Policy for mandatory seasonal influenza immunization for civilian health care personnel who provide direct patient care in Department of Defense military treatment facilities 4 April 2008. Military Vaccine Agency Falls Church VA. https:\/\/www.vaccines.mil\/documents\/1169HCPFluHAPolicy_08_005.pdf . Accessed 28 January 2015."},{"key":"e_1_3_2_269_2","unstructured":"Military Vaccine Agency Vaccine Healthcare Centers Network. 2005. Mandatory influenza vaccination for all DoD health care workers 19 December 2005. Military Vaccine Agency Falls Church VA. http:\/\/www.vaccines.mil\/documents\/923HCWflu.pdf . Accessed 28 January 2015."},{"issue":"10","key":"e_1_3_2_270_2","first-page":"20","article-title":"Surveillance snapshot: influenza immunization among U.S. Armed Forces healthcare workers, August 2008-April 2014","volume":"21","author":"Armed Forces Health Surveillance Center","year":"2014","unstructured":"Armed Forces Health Surveillance Center. 2014. Surveillance snapshot: influenza immunization among U.S. Armed Forces healthcare workers, August 2008-April 2014. MSMR 21(10):20.","journal-title":"MSMR"},{"key":"e_1_3_2_271_2","first-page":"805","article-title":"Influenza vaccination coverage among health care personnel\u2014United States, 2013-14 influenza season","volume":"63","author":"Black CL","year":"2014","unstructured":"Black CL , Yue X , Ball SW , Donahue SM , Izrael D , de Perio MA , Laney AS , Lindley MC , Graitcer SB , Lu PJ , Williams WW , Bridges CB , DiSogra C , Sokolowski J , Walker DK , Greby SM . 2014. Influenza vaccination coverage among health care personnel\u2014United States, 2013-14 influenza season. MMWR Morb Mortal Wkly Rep 63:805\u2013811.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_2_272_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(99)00434-X"},{"key":"e_1_3_2_273_2","doi-asserted-by":"publisher","DOI":"10.1093\/epirev\/mxj003"},{"key":"e_1_3_2_274_2","doi-asserted-by":"publisher","DOI":"10.7205\/MILMED-D-12-00345"},{"key":"e_1_3_2_275_2","doi-asserted-by":"publisher","DOI":"10.1586\/erv.09.9"},{"key":"e_1_3_2_276_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu580"},{"key":"e_1_3_2_277_2","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-153"},{"key":"e_1_3_2_278_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.07.048"},{"key":"e_1_3_2_279_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(11)70295-X"},{"key":"e_1_3_2_280_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041435"},{"key":"e_1_3_2_281_2","first-page":"1133","article-title":"Respiratory syncytial virus\u2014United States, July 2012-June 2014","volume":"63","author":"Haynes AK","year":"2014","unstructured":"Haynes AK , Prill MM , Iwane MK , Gerber SI . 2014. Respiratory syncytial virus\u2014United States, July 2012-June 2014. MMWR Morb Mortal Wkly Rep 63:1133\u20131136.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_2_282_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/163.4.693"},{"key":"e_1_3_2_283_2","first-page":"225","article-title":"Pattern of respiratory virus infections in army recruits","volume":"74","author":"Lennette EH","year":"1961","unstructured":"Lennette EH , Stallones RA . 1961. Pattern of respiratory virus infections in army recruits. Am J Hyg (Lond) 74:225\u2013233.","journal-title":"Am J Hyg (Lond)"},{"key":"e_1_3_2_284_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196207122670204"},{"key":"e_1_3_2_285_2","first-page":"499","article-title":"Acute respiratory disease associated with pulmonary involvement in military servicement in The Netherlands. A serologic and bacteriologic survey, January 1967 to January 1968","volume":"100","author":"Hers JF","year":"1969","unstructured":"Hers JF , Masurel N , Gans JC . 1969. Acute respiratory disease associated with pulmonary involvement in military servicement in The Netherlands. A serologic and bacteriologic survey, January 1967 to January 1968. Am Rev Respir Dis 100:499\u2013506.","journal-title":"Am Rev Respir Dis"},{"key":"e_1_3_2_286_2","first-page":"179","article-title":"Acute respiratory disease in the United States Army in the Republic of Vietnam, 1965-1970","volume":"48","author":"Sanford JP","year":"1975","unstructured":"Sanford JP . 1975. Acute respiratory disease in the United States Army in the Republic of Vietnam, 1965-1970. Yale J Biol Med 48:179\u2013184.","journal-title":"Yale J Biol Med"},{"key":"e_1_3_2_287_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0114871"},{"key":"e_1_3_2_288_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2011.08.006"},{"key":"e_1_3_2_289_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197602192940803"},{"key":"e_1_3_2_290_2","first-page":"806","article-title":"Parental smoking, presence of older siblings, and family history of asthma increase risk of bronchiolitis","volume":"140","author":"McConnochie KM","year":"1986","unstructured":"McConnochie KM , Roghmann KJ . 1986. Parental smoking, presence of older siblings, and family history of asthma increase risk of bronchiolitis. Am J Dis Child 140:806\u2013812.","journal-title":"Am J Dis Child"},{"key":"e_1_3_2_291_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2007.12.035"},{"key":"e_1_3_2_292_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01947-07"},{"key":"e_1_3_2_293_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02582-10"},{"key":"e_1_3_2_294_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01118-10"},{"key":"e_1_3_2_295_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2012.06.019"},{"key":"e_1_3_2_296_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.23970"},{"key":"e_1_3_2_297_2","unstructured":"Food and Drug Administration. 13 July 2012. FDA 510(k) for Simplexa Flu A\/B & RSV Direct. Food and Drug Administration Silver Spring MD. http:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf12\/K120413.pdf . Accessed 12 February 2015."},{"key":"e_1_3_2_298_2","unstructured":"Food and Drug Administration. 22 November 2014. FDA 510(k) for Xpert Flu\/RSV XC assay. Food and Drug Administration Silver Spring MD. http:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf14\/K142045.pdf . Accessed 12 February 2015."},{"key":"e_1_3_2_299_2","unstructured":"Food and Drug Administration. 6 September 2013. FDA 510(k) for Quidel Molecular RSV + hMPV assay. Food and Drug Administration Silver Spring MD. http:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf13\/K131813.pdf . Accessed 12 February 2015."},{"key":"e_1_3_2_300_2","first-page":"916","article-title":"Aerosol consensus statement\u20141991","volume":"36","author":"American Association for Respiratory Care","year":"1991","unstructured":"American Association for Respiratory Care. 1991. Aerosol consensus statement\u20141991. Respir Care 36:916\u2013921.","journal-title":"Respir Care"},{"key":"e_1_3_2_301_2","first-page":"24834","article-title":"Virazole (ribavirin)","volume":"53","author":"Federal Register","year":"1988","unstructured":"Federal Register. 1988. Virazole (ribavirin). Fed Regist 53:24834\u201324847.","journal-title":"Fed Regist"},{"key":"e_1_3_2_302_2","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1177\/135965350701200S03.1","article-title":"Respiratory syncytial virus infection in adults","volume":"12","author":"Murata Y","year":"2007","unstructured":"Murata Y , Falsey AR . 2007. Respiratory syncytial virus infection in adults. Antivir Ther 12:659\u2013670.","journal-title":"Antivir Ther"},{"key":"e_1_3_2_303_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit639"},{"key":"e_1_3_2_304_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1401184"},{"key":"e_1_3_2_305_2","unstructured":"Gilead Sciences Inc. 20 May 2014. Press release. Gilead's investigational GS-5806 reduces viral load and clinical symptoms in phase 2 respiratory syncytial virus (RSV) challenge study in adults. Gilead Sciences Inc Foster City CA. http:\/\/www.gilead.com\/news\/press-releases\/2014\/5\/gileads-investigational-gs5806-reduces-viral-load-and-clinical-symptoms-in-phase-2-respiratory-syncytial-virus-rsv-challenge-study-in-adults . Accessed 28 January 2015."},{"key":"e_1_3_2_306_2","doi-asserted-by":"publisher","DOI":"10.7205\/MILMED.170.4S.66"},{"key":"e_1_3_2_307_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.102.3.531"},{"key":"e_1_3_2_308_2","doi-asserted-by":"publisher","DOI":"10.1067\/S0022-3476(03)00454-2"},{"key":"e_1_3_2_309_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit512"},{"key":"e_1_3_2_310_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a120955"},{"key":"e_1_3_2_311_2","first-page":"1305","volume-title":"Fields virology","author":"Lai MMC","year":"2007","unstructured":"Lai MMC , Perlman S , Anderson LJ . 2007. Coronaviridae, p 1305\u20131356. In Knipe DM , Howley PM , Griffin DE , Lamb RA , Martin MA , Roizman B , Straus SE (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.","edition":"5"},{"key":"e_1_3_2_312_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.05320-0"},{"key":"e_1_3_2_313_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1143"},{"key":"e_1_3_2_314_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cll.2009.07.007"},{"key":"e_1_3_2_315_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2007.10.007"},{"key":"e_1_3_2_316_2","first-page":"621","article-title":"Coronavirus infections in military recruits. Three-year study with coronavirus strains OC43 and 229E","volume":"109","author":"Wenzel RP","year":"1974","unstructured":"Wenzel RP , Hendley JO , Davies JA , Gwaltney JM, Jr . 1974. Coronavirus infections in military recruits. Three-year study with coronavirus strains OC43 and 229E. Am Rev Respir Dis 109:621\u2013624.","journal-title":"Am Rev Respir Dis"},{"key":"e_1_3_2_317_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1211721"},{"key":"e_1_3_2_318_2","first-page":"431","article-title":"First confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in the United States, updated information on the epidemiology of MERS-CoV infection, and guidance for the public, clinicians, and public health authorities\u2014May 2014","volume":"63","author":"Bialek SR","year":"2014","unstructured":"Bialek SR , Allen D , Alvarado-Ramy F , Arthur R , Balajee A , Bell D , Best S , Blackmore C , Breakwell L , Cannons A , Brown C , Cetron M , Chea N , Chommanard C , Cohen N , Conover C , Crespo A , Creviston J , Curns AT , Dahl R , Dearth S , DeMaria A , Echols F , Erdman DD , Feikin D , Frias M , Gerber SI , Gulati R , Hale C , Haynes LM , Heberlein-Larson L , Holton K , Ijaz K , Kapoor M , Kohl K , Kuhar DT , Kumar AM , Kundich M , Lippold S , Liu L , Lovchik JC , Madoff L , Martell S , Matthews S , Moore J , Murray LR , Onofrey S , Pallansch MA , Pesik N , Pham H , . 2014. First confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in the United States, updated information on the epidemiology of MERS-CoV infection, and guidance for the public, clinicians, and public health authorities\u2014May 2014. MMWR Morb Mortal Wkly Rep 63:431\u2013436.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_2_319_2","unstructured":"Centers for Disease Control and Prevention. 4 February 2015. Middle East respiratory syndrome (MERS). Centers for Disease Control and Prevention Atlanta GA. http:\/\/www.cdc.gov\/coronavirus\/mers\/ . Accessed 19 May 2015."},{"key":"e_1_3_2_320_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2015.01.021"},{"key":"e_1_3_2_321_2","first-page":"61","article-title":"Update on the epidemiology of Middle East respiratory syndrome coronavirus (MERS-CoV) infection, and guidance for the public, clinicians, and public health authorities\u2014January 2015","volume":"64","author":"Rha B","year":"2015","unstructured":"Rha B , Rudd J , Feikin D , Watson J , Curns AT , Swerdlow DL , Pallansch MA , Gerber SI . 2015. Update on the epidemiology of Middle East respiratory syndrome coronavirus (MERS-CoV) infection, and guidance for the public, clinicians, and public health authorities\u2014January 2015. MMWR Morb Mortal Wkly Rep 64:61\u201362.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_2_322_2","unstructured":"World Health Organization. 18 May 2015. Middle East respiratory syndrome coronavirus (MERS-CoV)\u2014United Arab Emirates. World Health Organization Geneva Switzerland. http:\/\/www.who.int\/csr\/don\/18-may-2015-mers-are\/en\/ . Accessed 20 May 2015."},{"key":"e_1_3_2_323_2","unstructured":"World Health Organization. 26 March 2015. Middle East respiratory syndrome coronavirus (MERS-CoV)\u2014Saudi Arabia. World Health Organization Geneva Switzerland. http:\/\/www.who.int\/csr\/don\/26-march-2015-mers-saudi-arabia\/en\/ . Accessed 30 March 2015."},{"key":"e_1_3_2_324_2","unstructured":"Centers for Disease Control and Prevention. 26 January 2015. Middle East respiratory syndrome (MERS). Centers for Disease Control and Prevention Atlanta GA. http:\/\/www.cdc.gov\/coronavirus\/mers\/ . Accessed 28 January 2015."},{"key":"e_1_3_2_325_2","unstructured":"World Health Organization. 11 June 2014. Middle East respiratory syndrome coronavirus (MERS-CoV) summary and literature update as of 11 June 2014. World Health Organization Geneva Switzerland. http:\/\/www.who.int\/csr\/disease\/coronavirus_infections\/archive_updates\/en\/index.html . Accessed 28 January 2015."},{"key":"e_1_3_2_326_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1308698"},{"key":"e_1_3_2_327_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu359"},{"key":"e_1_3_2_328_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2014.06.019"},{"key":"e_1_3_2_329_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1408636"},{"key":"e_1_3_2_330_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu812"},{"key":"e_1_3_2_331_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70304-9"},{"key":"e_1_3_2_332_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2014.05.001"},{"key":"e_1_3_2_333_2","doi-asserted-by":"publisher","DOI":"10.1371\/currents.outbreaks.98d2f8f3382d84f390736cd5f5fe133c"},{"key":"e_1_3_2_334_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1405858"},{"key":"e_1_3_2_335_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(73)80582-7"},{"key":"e_1_3_2_336_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.66.1.124"},{"key":"e_1_3_2_337_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.102.2.291"},{"key":"e_1_3_2_338_2","doi-asserted-by":"publisher","DOI":"10.1086\/339881"},{"key":"e_1_3_2_339_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(03)00171-9"},{"key":"e_1_3_2_340_2","doi-asserted-by":"publisher","DOI":"10.1086\/377612"},{"key":"e_1_3_2_341_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2005.00971.x"},{"key":"e_1_3_2_342_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13410-1"},{"key":"e_1_3_2_343_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.3.374"},{"key":"e_1_3_2_344_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13412-5"},{"key":"e_1_3_2_345_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.21.JOC30885"},{"key":"e_1_3_2_346_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.3.367"},{"key":"e_1_3_2_347_2","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.181.1.1810011"},{"key":"e_1_3_2_348_2","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.181.1.1810003"},{"key":"e_1_3_2_349_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2283030541"},{"key":"e_1_3_2_350_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030685"},{"key":"e_1_3_2_351_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu226"},{"key":"e_1_3_2_352_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2014.09.003"},{"key":"e_1_3_2_353_2","unstructured":"Stone J . 5 May 2014. Muddled about MERS? Here's a quick guide. Scientific American. http:\/\/blogs.scientificamerican.com\/molecules-to-medicine\/2014\/05\/05\/muddled-about-mers-heres-a-quick-guide\/ . Accessed 6 May 2014."},{"key":"e_1_3_2_354_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu635"},{"key":"e_1_3_2_355_2","doi-asserted-by":"crossref","unstructured":"World Health Organization. 19 November 2013. Frequently asked questions on Middle East respiratory syndrome coronavirus (MERS-CoV). World Health Organization Geneva Switzerland. http:\/\/www.who.int\/csr\/disease\/coronavirus_infections\/faq\/en\/ . Accessed 12 February 2014.","DOI":"10.2807\/1560-7917.ES2014.19.16.20781"},{"key":"e_1_3_2_356_2","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1177\/135965350701200S01.1","article-title":"Human coronaviruses: what do they cause?","volume":"12","author":"van der Hoek L","year":"2007","unstructured":"van der Hoek L . 2007. Human coronaviruses: what do they cause? Antivir Ther 12:651\u2013658.","journal-title":"Antivir Ther"},{"key":"e_1_3_2_357_2","unstructured":"Centers for Disease Control and Prevention. 10 January 2014. Interim guidelines for collecting handling and testing clinical specimens from patients under investigation (PUIs) for Middle East respiratory syndrome coronavirus (MERS-CoV) version 2. Centers for Disease Control and Prevention Atlanta GA. http:\/\/www.cdc.gov\/coronavirus\/mers\/downloads\/guidelines-clinical-specimens.pdf . Accessed 29 October 2014."},{"key":"e_1_3_2_358_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030747"},{"key":"e_1_3_2_359_2","first-page":"368","article-title":"Detection of SARS-CoV RNA in stool samples of SARS patients by nest RT-PCR and its clinical value","volume":"25","author":"Ren Y","year":"2003","unstructured":"Ren Y , Ding HG , Wu QF , Chen WJ , Chen D , Bao ZY , Yang L , Zhao CH , Wang J . 2003. Detection of SARS-CoV RNA in stool samples of SARS patients by nest RT-PCR and its clinical value. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 25:368\u2013371. (In Chinese.)","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"e_1_3_2_360_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-1406"},{"key":"e_1_3_2_361_2","unstructured":"Centers for Disease Control and Prevention. 14 May 2014. Interim guidance for health professionals: patients in U.S. who should be evaluated for Middle East respiratory syndrome coronavirus (MERS-CoV) infection. Centers for Disease Control and Prevention Atlanta GA. http:\/\/www.cdc.gov\/coronavirus\/mers\/interim-guidance.html . Accessed 15 May 2014."},{"key":"e_1_3_2_362_2","unstructured":"Armed Forces Health Surveillance Center. 27 May 2014. Department of Defense (AFHSC): detecting and reporting DoD cases of Middle Eastern respiratory syndrome coronavirus (MERS-CoV) infection. Guidance as of 27 May 2014. Armed Forces Health Surveillance Center Silver Spring MD. http:\/\/www.afhsc.mil\/documents\/pubs\/documents\/Detecting_and_Reporting_DoD_Cases_of_MERS-CoV_Infection_2014_05_27.pdf . Accessed 28 January 2015."},{"key":"e_1_3_2_363_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1103.040629"},{"key":"e_1_3_2_364_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2014.02.009"},{"key":"e_1_3_2_365_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2014.10.002"},{"key":"e_1_3_2_366_2","unstructured":"Centers for Disease Control and Prevention. 15 May 2014. Interim infection prevention and control recommendations for hospitalized patients with Middle East respiratory syndrome coronavirus (MERS-CoV). Centers for Disease Control and Prevention Atlanta GA. http:\/\/www.cdc.gov\/coronavirus\/mers\/infection-prevention-control.html . Accessed 15 May 2014."},{"key":"e_1_3_2_367_2","unstructured":"World Health Organization. 5 February 2015. WHO statement on the Eighth Meeting of the IHR Emergency Committee regarding MERS-CoV. World Health Organization Geneva Switzerland. http:\/\/www.who.int\/mediacentre\/news\/statements\/2015\/8th-mers-emergency-committee\/en\/ . Accessed 11 February 2015."},{"key":"e_1_3_2_368_2","unstructured":"World Health Organization. 3 June 2014. World-travel advice on MERS-CoV for pilgrimages. World Health Organization Geneva Switzerland. http:\/\/www.who.int\/ith\/updates\/20140603\/en\/ . Accessed 17 June 2014."},{"key":"e_1_3_2_369_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13265-5"},{"key":"e_1_3_2_370_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(05)01307-1"},{"key":"e_1_3_2_371_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030343"},{"key":"e_1_3_2_372_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(14)70920-X"},{"key":"e_1_3_2_373_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3008140"},{"key":"e_1_3_2_374_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1402074111"},{"key":"e_1_3_2_375_2","unstructured":"World Health Organization. 2014. WHO-ISARIC joint MERS-CoV Outbreak Readiness Workshop\u2014clinical management and potential use of convalescent plasma 10 to 12 December 2013. World Health Organization Geneva Switzerland. http:\/\/www.who.int\/csr\/disease\/coronavirus_infections\/MERS_outbreak_readiness_workshop.pdf?ua=1 . Accessed 28 January 2015."},{"key":"e_1_3_2_376_2","unstructured":"National Institute of Allergy and Infectious Diseases. 27 May 2014. Middle East respiratory syndrome coronavirus (MERS-CoV) research. National Institute of Allergy and Infectious Diseases Bethesda MD. http:\/\/www.niaid.nih.gov\/topics\/coronavirus\/research\/Pages\/MERSCoV.aspx . Accessed 28 January 2015."},{"key":"e_1_3_2_377_2","unstructured":"World Health Organization. 11 February 2013. Interim guidance document. Clinical management of severe acute respiratory infections when novel coronavirus is suspected: what to do and what not to do. World Health Organization Geneva Switzerland. http:\/\/www.who.int\/csr\/disease\/coronavirus_infections\/InterimGuidance_ClinicalManagement_NovelCoronavirus_11Feb13u.pdf?ua=1 . Accessed 29 January 2015."},{"key":"e_1_3_2_378_2","doi-asserted-by":"publisher","DOI":"10.1038\/89098"},{"key":"e_1_3_2_379_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-443-06839-3.00156-9"},{"key":"e_1_3_2_380_2","unstructured":"Centers for Disease Control and Prevention. 5 November 2012. Human parainfluenza viruses (HPIVs) HPIV seasons. Centers for Disease Control and Prevention Atlanta GA. http:\/\/www.cdc.gov\/parainfluenza\/seasons.html . Accessed 8 December 2014."},{"key":"e_1_3_2_381_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20243"},{"key":"e_1_3_2_382_2","doi-asserted-by":"publisher","DOI":"10.1086\/526776"},{"key":"e_1_3_2_383_2","first-page":"909","article-title":"Outbreaks of human metapneumovirus in two skilled nursing facilities\u2014West Virginia and Idaho, 2011-2012","volume":"62","author":"Centers for Disease Control and Prevention","year":"2013","unstructured":"Centers for Disease Control and Prevention. 2013. Outbreaks of human metapneumovirus in two skilled nursing facilities\u2014West Virginia and Idaho, 2011-2012. MMWR Morb Mortal Wkly Rep 62:909\u2013913.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_2_384_2","unstructured":"Naval Health Research Center Operational Infectious Diseases Department. 2014. Febrile respiratory illness (FRI) surveillance update 27 December 2014. Naval Health Research Center San Diego CA. http:\/\/www.med.navy.mil\/sites\/nhrc\/geis\/Documents\/FRIUpdate.pdf . Accessed 28 January 2015."},{"key":"e_1_3_2_385_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-204"},{"key":"e_1_3_2_386_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00014-06"},{"key":"e_1_3_2_387_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2014.03.1394"},{"key":"e_1_3_2_388_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cll.2009.10.002"},{"key":"e_1_3_2_389_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2006.140299"},{"key":"e_1_3_2_390_2","doi-asserted-by":"publisher","DOI":"10.1086\/340518"},{"key":"e_1_3_2_391_2","doi-asserted-by":"publisher","DOI":"10.1086\/344319"},{"key":"e_1_3_2_392_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2007.06.006"},{"key":"e_1_3_2_393_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01926-07"},{"key":"e_1_3_2_394_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.3.981-986.2004"},{"key":"e_1_3_2_395_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0906.030009"},{"key":"e_1_3_2_396_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00210-07"},{"key":"e_1_3_2_397_2","unstructured":"Food and Drug Administration. 9 October 2014. FDA 510(k) for Lyra parainfluenza assay. Food and Drug Administration Silver Spring MD. http:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf14\/K141927.pdf . Accessed 16 February 2015."},{"key":"e_1_3_2_398_2","unstructured":"Federal Register. 2015. Determination and declaration regarding emergency use of new in vitro diagnostics for detection of enterovirus D68. Fed Regist 80:10685\u201310686. https:\/\/www.federalregister.gov\/articles\/2015\/02\/27\/2015-04121\/determination-and-declaration-regarding-emergency-use-of-new-in-vitro-diagnostics-for-detection-of . Accessed 8 April 2015."},{"key":"e_1_3_2_399_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-976493"},{"key":"e_1_3_2_400_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.168.22.2489"},{"key":"e_1_3_2_401_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2014.01.003"},{"key":"e_1_3_2_402_2","doi-asserted-by":"publisher","DOI":"10.1086\/651603"},{"key":"e_1_3_2_403_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-3542(03)00153-0"},{"key":"e_1_3_2_404_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07295.x"},{"key":"e_1_3_2_405_2","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12177"},{"key":"e_1_3_2_406_2","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piu039"},{"key":"e_1_3_2_407_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00793-07"},{"key":"e_1_3_2_408_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.04.075"},{"key":"e_1_3_2_409_2","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e318168b76f"},{"key":"e_1_3_2_410_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60319-0"},{"key":"e_1_3_2_411_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.02.088"},{"key":"e_1_3_2_412_2","doi-asserted-by":"publisher","DOI":"10.1093\/milmed\/159.10.629"},{"key":"e_1_3_2_413_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a117076"},{"key":"e_1_3_2_414_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0749-3797(03)00114-4"},{"key":"e_1_3_2_415_2","volume-title":"Abstr 31st Intersci Conf Antimicrob Agents Chemother","author":"Reido F","year":"1991","unstructured":"Reido F , Schwartz B , Giono S , Hierholzer J , Ostroff S , Groover J . 1991. Pneumococcal pneumonia outbreak in a ranger training battalion, Georgia, abstr 106. Abstr 31st Intersci Conf Antimicrob Agents Chemother."},{"key":"e_1_3_2_416_2","doi-asserted-by":"publisher","DOI":"10.1093\/milmed\/168.1.1"},{"key":"e_1_3_2_417_2","doi-asserted-by":"publisher","DOI":"10.1086\/382879"},{"key":"e_1_3_2_418_2","first-page":"36","article-title":"Efficacy of pneumococcal vaccine in military units","volume":"2","author":"Zhogolev SD","year":"2003","unstructured":"Zhogolev SD , Mosiagin VD , Demidovich VU , Mel'nichenko PI , Ogarkov PI . 2003. Efficacy of pneumococcal vaccine in military units. Zh Mikrobiol Epidemiol Immunobiol 2:36\u201342. (In Russian.)","journal-title":"Zh Mikrobiol Epidemiol Immunobiol"},{"key":"e_1_3_2_419_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.06.031"},{"key":"e_1_3_2_420_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0377-1237(05)80111-X"},{"key":"e_1_3_2_421_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0463.2009.02463.x"},{"key":"e_1_3_2_422_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-11-157"},{"key":"e_1_3_2_423_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(14)70131-6"},{"key":"e_1_3_2_424_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir749"},{"key":"e_1_3_2_425_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00058-05"},{"key":"e_1_3_2_426_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir753"},{"key":"e_1_3_2_427_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1408.071313"},{"key":"e_1_3_2_428_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1077"},{"key":"e_1_3_2_429_2","doi-asserted-by":"publisher","DOI":"10.1086\/656333"},{"key":"e_1_3_2_430_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01040-13"},{"key":"e_1_3_2_431_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2013.03.005"},{"key":"e_1_3_2_432_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01709542"},{"key":"e_1_3_2_433_2","volume-title":"Pneumonia: with special reference to pneumococcus lobar pneumonia","author":"Heffron R","year":"1979","unstructured":"Heffron R . 1979. Pneumonia: with special reference to pneumococcus lobar pneumonia. Harvard University Press, Cambridge, MA."},{"key":"e_1_3_2_434_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1987.03390020055020"},{"key":"e_1_3_2_435_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-443-06839-3.00200-9"},{"key":"e_1_3_2_436_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199512143332408"},{"key":"e_1_3_2_437_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/18.4.501"},{"key":"e_1_3_2_438_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.239.25.2671"},{"key":"e_1_3_2_439_2","doi-asserted-by":"publisher","DOI":"10.1086\/421497"},{"key":"e_1_3_2_440_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.25.5.758-762.1987"},{"key":"e_1_3_2_441_2","first-page":"845","article-title":"The nonvalue of sputum culture in the diagnosis of pneumococcal pneumonia","volume":"103","author":"Barrett-Connor E","year":"1971","unstructured":"Barrett-Connor E . 1971. The nonvalue of sputum culture in the diagnosis of pneumococcal pneumonia. Am Rev Respir Dis 103:845\u2013848.","journal-title":"Am Rev Respir Dis"},{"key":"e_1_3_2_442_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1312885"},{"key":"e_1_3_2_443_2","doi-asserted-by":"publisher","DOI":"10.1086\/511159"},{"key":"e_1_3_2_444_2","unstructured":"Alere. 2014. Alere BinaxNOW Streptococcus pneumoniae antigen card. Alere Waltham MA. http:\/\/www.alere.com\/us\/en\/product-details\/binaxnow-streptococcus-pneumoniae.html . Accessed 28 January 2015."},{"key":"e_1_3_2_445_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.43.7.3221-3226.2005"},{"key":"e_1_3_2_446_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01636-09"},{"key":"e_1_3_2_447_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01480-08"},{"key":"e_1_3_2_448_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01742-13"},{"key":"e_1_3_2_449_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir048"},{"key":"e_1_3_2_450_2","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.137.6.1213"},{"key":"e_1_3_2_451_2","first-page":"317","article-title":"Cavitation in bacteremic pneumococcal pneumonia. Causal role of mixed infection with anaerobic bacteria","volume":"129","author":"Leatherman JW","year":"1984","unstructured":"Leatherman JW , Iber C , Davies SF . 1984. Cavitation in bacteremic pneumococcal pneumonia. Causal role of mixed infection with anaerobic bacteria. Am Rev Respir Dis 129:317\u2013321.","journal-title":"Am Rev Respir Dis"},{"key":"e_1_3_2_452_2","doi-asserted-by":"publisher","DOI":"10.1016\/0007-0971(86)90068-9"},{"key":"e_1_3_2_453_2","unstructured":"Clinical and Laboratory Standards Institute. 2015. Performance standards for antimicrobial susceptibility testing; twenty-fifth informational supplement. CLSI document M100-S25. Clinical and Laboratory Standards Institute Wayne PA. http:\/\/shop.clsi.org\/c.1253739\/site\/Sample_pdf\/M100S25_sample.pdf . Accessed 28 January 2015."},{"key":"e_1_3_2_454_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2011.05.035"},{"key":"e_1_3_2_455_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1406330"},{"key":"e_1_3_2_456_2","doi-asserted-by":"publisher","DOI":"10.1086\/429919"},{"key":"e_1_3_2_457_2","doi-asserted-by":"publisher","DOI":"10.1086\/433192"},{"key":"e_1_3_2_458_2","doi-asserted-by":"publisher","DOI":"10.1086\/596051"},{"key":"e_1_3_2_459_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)00098-4"},{"key":"e_1_3_2_460_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200311-1578OC"},{"key":"e_1_3_2_461_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.161.15.1837"},{"key":"e_1_3_2_462_2","doi-asserted-by":"publisher","DOI":"10.1086\/367541"},{"key":"e_1_3_2_463_2","doi-asserted-by":"publisher","DOI":"10.1155\/2004\/461392"},{"key":"e_1_3_2_464_2","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.56.4.296"},{"key":"e_1_3_2_465_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.51.2.179"},{"key":"e_1_3_2_466_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh519"},{"key":"e_1_3_2_467_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2004.07.023"},{"key":"e_1_3_2_468_2","volume-title":"UpToDate","author":"Marrie TJ","year":"2014","unstructured":"Marrie TJ , Tuomanen EI . 2014. Pneumococcal pneumonia in adults. In Basow D (ed), UpToDate. UpToDate, Waltham, MA."},{"key":"e_1_3_2_469_2","doi-asserted-by":"publisher","DOI":"10.1086\/313645"},{"key":"e_1_3_2_470_2","first-page":"129","article-title":"Pneumonia epidemic caused by a virulent strain of Streptococcus pneumoniae serotype 1 in Nunavik, Quebec","volume":"28","author":"Proulx JF","year":"2002","unstructured":"Proulx JF , Dery S , Jette LP , Ismael J , Libman M , De Wals P . 2002. Pneumonia epidemic caused by a virulent strain of Streptococcus pneumoniae serotype 1 in Nunavik, Quebec. Can Commun Dis Rep 28:129\u2013131.","journal-title":"Can Commun Dis Rep"},{"key":"e_1_3_2_471_2","first-page":"283","volume-title":"The pneumococcus","author":"Dagan R","year":"2004","unstructured":"Dagan R , Lipsitch M . 2004. Changing the ecology of pneumococci with antibiotics and vaccines, p 283\u2013313. In Tuomanen EI , Mitchell TJ , Morrison DA , Spratt BG (ed), The pneumococcus. ASM Press, Washington, DC."},{"key":"e_1_3_2_472_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/174.6.1271"},{"key":"e_1_3_2_473_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.12.058"},{"key":"e_1_3_2_474_2","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2015.957191"},{"key":"e_1_3_2_475_2","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2755"},{"key":"e_1_3_2_476_2","volume-title":"The epidemiology of hemolytic Streptococcus during World War II in the United States Navy","author":"Coburn AFY","year":"1949","unstructured":"Coburn AFY , Donald C . 1949. The epidemiology of hemolytic Streptococcus during World War II in the United States Navy. Waverly Press Inc, Baltimore, MD."},{"key":"e_1_3_2_477_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.97.6.964"},{"key":"e_1_3_2_478_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/172.1.124"},{"key":"e_1_3_2_479_2","doi-asserted-by":"publisher","DOI":"10.1086\/516275"},{"key":"e_1_3_2_480_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1469-0691.2000.00001.x"},{"issue":"1","key":"e_1_3_2_481_2","first-page":"8","article-title":"Focal outbreaks of group A beta hemolytic streptococcus, Fort Leonard Wood, Missouri, and Fort Knox, Kentucky","volume":"3","author":"Greenup R","year":"1997","unstructured":"Greenup R , Hack DC , Young LA . 1997. Focal outbreaks of group A beta hemolytic streptococcus, Fort Leonard Wood, Missouri, and Fort Knox, Kentucky. MSMR 3(1):8\u201314.","journal-title":"MSMR"},{"key":"e_1_3_2_482_2","volume-title":"Abstr 50th Annu Am Soc Trop Med Hyg Meet","author":"Sanchez JL","year":"2001","unstructured":"Sanchez JL , Kolavic-Gray SA , Polyak CS , Craig SC , Feighner B , Alsip B , James G , Gay S , Parrado C , Gray GC , Hudspeth M , Janoff E . 2001. Randomized, double-blind, placebo-controlled efficacy trial of 23-valent pneumococcal vaccine and benzathine penicillin G in the prevention of acute febrile respiratory disease and cellulitis among US military personnel>, abstr 349. Abstr 50th Annu Am Soc Trop Med Hyg Meet, Atlanta, GA."},{"key":"e_1_3_2_483_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.04.041"},{"key":"e_1_3_2_484_2","first-page":"106","article-title":"Outbreak of group A streptococcal pneumonia among Marine Corps recruits\u2014California, November 1-December 20, 2002","volume":"52","author":"Centers for Disease Control and Prevention","year":"2003","unstructured":"Centers for Disease Control and Prevention. 2003. Outbreak of group A streptococcal pneumonia among Marine Corps recruits\u2014California, November 1-December 20, 2002. MMWR Morb Mortal Wkly Rep 52:106\u2013109.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_2_485_2","doi-asserted-by":"publisher","DOI":"10.1086\/427502"},{"issue":"1","key":"e_1_3_2_486_2","first-page":"7","article-title":"Epidemiologic consultation (EPICON): outbreak of invasive group A streptococcal infections among trainees, Fort Leonard Wood, Missouri, 2006","volume":"13","author":"Cersovsky SB","year":"2007","unstructured":"Cersovsky SB , Hawley J , White D , Soltis B , Lee S , Sullivan T , Mabee M , Leggit J , Russell B , Wolf S . 2007. Epidemiologic consultation (EPICON): outbreak of invasive group A streptococcal infections among trainees, Fort Leonard Wood, Missouri, 2006. MSMR 13(1):7\u201310.","journal-title":"MSMR"},{"key":"e_1_3_2_487_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2007.12.027"},{"key":"e_1_3_2_488_2","unstructured":"Office of the Army Surgeon General. 2010. Army Acute Respiratory Disease Surveillance Program. Memorandum. DASG-PPM-NC 22 July 2010. Office of the Army Surgeon General Department of the Army Falls Church VA. http:\/\/www.afhsc.mil\/documents\/pubs\/documents\/Army_PDFs\/ARD_Surveillance_Program_Memo_22_JUL_10.pdf . Accessed 28 January 2015."},{"key":"e_1_3_2_489_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199107113250204"},{"key":"e_1_3_2_490_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-04579-7.00166-0"},{"key":"e_1_3_2_491_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-443-06839-3.00198-3"},{"key":"e_1_3_2_492_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199401000-00002"},{"key":"e_1_3_2_493_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-198607000-00012"},{"key":"e_1_3_2_494_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2013.03.003"},{"key":"e_1_3_2_495_2","doi-asserted-by":"publisher","DOI":"10.1086\/652291"},{"key":"e_1_3_2_496_2","first-page":"1071","article-title":"Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1)\u2014United States, May-August 2009","volume":"58","author":"Centers for Disease Control and Prevention","year":"2009","unstructured":"Centers for Disease Control and Prevention. 2009. Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1)\u2014United States, May-August 2009. MMWR Morb Mortal Wkly Rep 58:1071\u20131074.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_2_497_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2001.130233"},{"key":"e_1_3_2_498_2","unstructured":"Centers for Disease Control and Prevention. 8 February 2008. Introduction to emm typing: M protein gene (emm) typing Streptococcus pyogenes . Centers for Disease Control and Prevention Atlanta GA. http:\/\/www.cdc.gov\/streplab\/M-ProteinGene-typing.html . Accessed 28 January 2015."},{"key":"e_1_3_2_499_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.anpedi.2009.12.012"},{"key":"e_1_3_2_500_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis847"},{"key":"e_1_3_2_501_2","unstructured":"Brooks M . 2 April 2015. Rapid group A strep test clears FDA. MedScape. http:\/\/www.medscape.com\/viewarticle\/842544 . Accessed 6 April 2015."},{"key":"e_1_3_2_502_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu400"},{"key":"e_1_3_2_503_2","unstructured":"Food and Drug Administration. 13 September 2012. FDA 510(k) for illumigene group A Streptococcus nucleic acid amplification assay system. Food and Drug Administration Silver Spring MD. http:\/\/www.accessdata.fda.gov\/cdrh_docs\/reviews\/k122019.pdf . Accessed 8 April 2015."},{"key":"e_1_3_2_504_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00176-13"},{"key":"e_1_3_2_505_2","unstructured":"Food and Drug Administration. 4 November 2014. FDA 510(k) for Liat Strep A assay. Food and Drug Administration Silver Spring MD. http:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf14\/k141338.pdf . Accessed 8 April 2015."},{"key":"e_1_3_2_506_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2014.08.005"},{"key":"e_1_3_2_507_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu304"},{"key":"e_1_3_2_508_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9610(94)90240-2"},{"key":"e_1_3_2_509_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1950.02910370001001"},{"key":"e_1_3_2_510_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM195307022490101"},{"key":"e_1_3_2_511_2","first-page":"173","volume-title":"Military preventive medicine: mobilization and deployment","author":"Gunzenhauser JD","year":"2003","unstructured":"Gunzenhauser JD . 2003. Communicable disease control in basic training: programmatic aspects, p 173\u2013194. In Kelley PW (ed), Military preventive medicine: mobilization and deployment, vol 1. TMM Publications, Washington, DC."},{"key":"e_1_3_2_512_2","unstructured":"Armed Forces Epidemiological Board. 1959. Recommendation of the Ad Hoc Committee on Prophylaxis of Streptococcal Infections of the Commission on Streptococcal Diseases. Armed Services Epidemiological Board Falls Church VA. http:\/\/history.amedd.army.mil\/booksdocs\/historiesofcomsn\/section4.html . Accessed 28 January 2015."},{"key":"e_1_3_2_513_2","volume-title":"Penicillin prophylaxis regarding streptococcal disease in Navy and Marine Corps recruit facilities","author":"Armed Forces Epidemiological Board","year":"1983","unstructured":"Armed Forces Epidemiological Board. 1983. Penicillin prophylaxis regarding streptococcal disease in Navy and Marine Corps recruit facilities. Armed Services Epidemiological Board, Falls Church, VA."},{"key":"e_1_3_2_514_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/166.5.1006"},{"key":"e_1_3_2_515_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.79.6.649"},{"key":"e_1_3_2_516_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1961.03040150034009"},{"key":"e_1_3_2_517_2","first-page":"345","article-title":"Mycoplasma pneumoniae and adenovirus respiratory illnesses in military and university personnel, 1959-1966","volume":"97","author":"Mogabgab WJ","year":"1968","unstructured":"Mogabgab WJ . 1968. Mycoplasma pneumoniae and adenovirus respiratory illnesses in military and university personnel, 1959-1966. Am Rev Respir Dis 97:345\u2013358.","journal-title":"Am Rev Respir Dis"},{"key":"e_1_3_2_518_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-65-5-931"},{"key":"e_1_3_2_519_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a112330"},{"key":"e_1_3_2_520_2","doi-asserted-by":"publisher","DOI":"10.1093\/milmed\/159.4.292"},{"key":"e_1_3_2_521_2","doi-asserted-by":"publisher","DOI":"10.1093\/milmed\/162.8.524"},{"key":"e_1_3_2_522_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/17.3.420"},{"key":"e_1_3_2_523_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01926-09"},{"key":"e_1_3_2_524_2","doi-asserted-by":"publisher","DOI":"10.7205\/MILMED-D-10-00370"},{"key":"e_1_3_2_525_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.8.4.451"},{"key":"e_1_3_2_526_2","doi-asserted-by":"publisher","DOI":"10.1093\/milmed\/166.9.759"},{"key":"e_1_3_2_527_2","doi-asserted-by":"publisher","DOI":"10.1086\/313707"},{"key":"e_1_3_2_528_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-443-06839-3.00184-3"},{"key":"e_1_3_2_529_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-443-06839-3.00182-X"},{"key":"e_1_3_2_530_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/20.5.1174"},{"key":"e_1_3_2_531_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/172.5.1330"},{"key":"e_1_3_2_532_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/19.1.157"},{"key":"e_1_3_2_533_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.32.4.903-905.1994"},{"key":"e_1_3_2_534_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1525-1578(10)60501-6"},{"key":"e_1_3_2_535_2","first-page":"215","volume-title":"Epidemiology and prevention of vaccine-preventable diseases","author":"Centers for Disease Control and Prevention","year":"2012","unstructured":"Centers for Disease Control and Prevention. 2012. Pertussis, p 215\u2013232. In Atkinson W , Hamborsky J , Wolfe S (ed), Epidemiology and prevention of vaccine-preventable diseases, 12th ed. Public Health Foundation, Washington, DC.","edition":"12"},{"key":"e_1_3_2_536_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-198702000-00001"},{"key":"e_1_3_2_537_2","first-page":"197","article-title":"Pertussis outbreaks\u2014Massachusetts and Maryland, 1992","volume":"42","author":"Centers for Disease Control and Prevention","year":"1993","unstructured":"Centers for Disease Control and Prevention. 1993. Pertussis outbreaks\u2014Massachusetts and Maryland, 1992. MMWR Morb Mortal Wkly Rep 42:197\u2013200.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_2_538_2","first-page":"822","article-title":"Pertussis outbreak\u2014Vermont, 1996","volume":"46","author":"Centers for Disease Control and Prevention","year":"1997","unstructured":"Centers for Disease Control and Prevention. 1997. Pertussis outbreak\u2014Vermont, 1996. MMWR Morb Mortal Wkly Rep 46:822\u2013826.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_2_539_2","first-page":"517","article-title":"Pertussis epidemic\u2014Washington, 2012","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","unstructured":"Centers for Disease Control and Prevention. 2012. Pertussis epidemic\u2014Washington, 2012. MMWR Morb Mortal Wkly Rep 61:517\u2013522.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_2_540_2","first-page":"1129","article-title":"Pertussis epidemic\u2014California, 2014","volume":"63","author":"Winter K","year":"2014","unstructured":"Winter K , Glaser C , Watt J , Harriman K . 2014. Pertussis epidemic\u2014California, 2014. MMWR Morb Mortal Wkly Rep 63:1129\u20131132.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_2_541_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.146"},{"issue":"8","key":"e_1_3_2_542_2","first-page":"14","article-title":"Pertussis diagnoses among service members and other beneficiaries of the U.S. Military Health System, January 2005-June 2012","volume":"19","author":"Armed Forces Health Surveillance Center","year":"2012","unstructured":"Armed Forces Health Surveillance Center. 2012. Pertussis diagnoses among service members and other beneficiaries of the U.S. Military Health System, January 2005-June 2012. MSMR 19(8):14\u201317.","journal-title":"MSMR"},{"issue":"6","key":"e_1_3_2_543_2","first-page":"18","article-title":"Surveillance snapshot: states with the most pertussis diagnoses among service members and other beneficiaries of the Military Health System, January 2012-June 2014","volume":"21","author":"Armed Forces Health Surveillance Center","year":"2014","unstructured":"Armed Forces Health Surveillance Center. 2014. Surveillance snapshot: states with the most pertussis diagnoses among service members and other beneficiaries of the Military Health System, January 2012-June 2014. MSMR 21(6):18.","journal-title":"MSMR"},{"key":"e_1_3_2_544_2","doi-asserted-by":"publisher","DOI":"10.1086\/516099"},{"key":"e_1_3_2_545_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1103.040672"},{"key":"e_1_3_2_546_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.05.070"},{"key":"e_1_3_2_547_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.310.6975.299"},{"key":"e_1_3_2_548_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-443-06839-3.00230-7"},{"key":"e_1_3_2_549_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-1-4557-0090-5.00030-6"},{"key":"e_1_3_2_550_2","unstructured":"Centers for Disease Control and Prevention. 7 May 2012. Best practices for health care professionals on the use of polymerase chain reaction (PCR) for diagnosing pertussis. Centers for Disease Control and Prevention Atlanta GA. http:\/\/www.cdc.gov\/pertussis\/clinical\/downloads\/diagnosis-pcr-bestpractices.pdf . Accessed 28 January 2015."},{"key":"e_1_3_2_551_2","unstructured":"Centers for Disease Control and Prevention. 28 August 2013. Pertussis: diagnosis confirmation. Centers for Disease Control and Prevention Atlanta GA. http:\/\/www.cdc.gov\/pertussis\/clinical\/diagnostic-testing\/diagnosis-confirmation.html . Accessed 28 January 2015."},{"key":"e_1_3_2_552_2","unstructured":"Centers for Disease Control and Prevention. 28 August 2013. Pertussis treatment. Centers for Disease Control and Prevention Atlanta GA. http:\/\/www.cdc.gov\/pertussis\/clinical\/treatment.html . Accessed 28 January 2015."},{"key":"e_1_3_2_553_2","first-page":"1","article-title":"Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"46","author":"Centers for Disease Control and Prevention","year":"1997","unstructured":"Centers for Disease Control and Prevention. 1997. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommend Rep 46:1\u201325.","journal-title":"MMWR Recommend Rep"},{"key":"e_1_3_2_554_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2011-2594"},{"key":"e_1_3_2_555_2","first-page":"1","article-title":"Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","author":"Broder KR","year":"2006","unstructured":"Broder KR , Cortese MM , Iskander JK , Kretsinger K , Slade BA , Brown KH , Mijalski CM , Tiwari T , Weston EJ , Cohn AC , Srivastava PU , Moran JS , Schwartz B , Murphy TV . 2006. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommend Rep 55:1\u201334.","journal-title":"MMWR Recommend Rep"},{"key":"e_1_3_2_556_2","first-page":"1","article-title":"Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel","volume":"55","author":"Kretsinger K","year":"2006","unstructured":"Kretsinger K , Broder KR , Cortese MM , Joyce MP , Ortega-Sanchez I , Lee GM , Tiwari T , Cohn AC , Slade BA , Iskander JK , Mijalski CM , Brown KH , Murphy TV . 2006. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recommend Rep 55:1\u201337.","journal-title":"MMWR Recommend Rep"},{"key":"e_1_3_2_557_2","first-page":"468","article-title":"Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in adults aged 65 years and older\u2014Advisory Committee on Immunization Practices (ACIP), 2012","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","unstructured":"Centers for Disease Control and Prevention. 2012. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in adults aged 65 years and older\u2014Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep 61:468\u2013470.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_2_558_2","first-page":"1","article-title":"Immunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","unstructured":"Centers for Disease Control and Prevention. 2011. Immunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommend Rep 60:1\u201345.","journal-title":"MMWR Recommend Rep"},{"key":"e_1_3_2_559_2","first-page":"1424","article-title":"Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months\u2014Advisory Committee on Immunization Practices (ACIP), 2011","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","unstructured":"Centers for Disease Control and Prevention. 2011. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months\u2014Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 60:1424\u20131426.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_2_560_2","first-page":"131","article-title":"Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women\u2014Advisory Committee on Immunization Practices (ACIP), 2012","volume":"62","author":"Centers for Disease Control and Prevention","year":"2013","unstructured":"Centers for Disease Control and Prevention. 2013. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women\u2014Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep 62:131\u2013135.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_2_561_2","unstructured":"Department of the Army US Army Medical Command Headquarters. 2013. Army Medical Command Regulation 40-64. Medical Services: the Tuberculosis Surveillance and Control Program. Department of the Army Headquarters United States Army Medical Command; 26 November 2013. US Army Medical Command Headquarters San Antonio TX. https:\/\/www.vaccines.mil\/documents\/1703_MEDCOM_Reg_40-64_TB_Program.pdf . Accessed 28 January 2015."},{"key":"e_1_3_2_562_2","unstructured":"Bushnell G . 1928. Tuberculosis vol IX: communicable and other diseases. Office of the Surgeon General Department of the Army Washington DC. http:\/\/archive.org\/stream\/WW1ArmyMedDeptHistV9\/WW1ArmyMedDeptHistV9_djvu.txt . Accessed 28 January 2015."},{"key":"e_1_3_2_563_2","unstructured":"Long E Jablon S . 1955. Tuberculosis in the Army of the U.S. in World War II. US Government Printing Office Washington DC. http:\/\/history.amedd.army.mil\/booksdocs\/wwii\/infectiousdisvolii\/chapter11.htm . Accessed 28 January 2015."},{"key":"e_1_3_2_564_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.37.4.412"},{"key":"e_1_3_2_565_2","unstructured":"Leedham CL . 1954. Tuberculosis. Recent advances in medicine and surgery based on professional medical experiences in Japan and Korea 1950-1953 vol II. Office of the Surgeon General Department of the Army Washington DC. http:\/\/history.amedd.army.mil\/booksdocs\/korea\/recad2\/ch4-1.html ."},{"key":"e_1_3_2_566_2","doi-asserted-by":"publisher","DOI":"10.1164\/arrd.1972.106.2.273"},{"key":"e_1_3_2_567_2","doi-asserted-by":"publisher","DOI":"10.7205\/MILMED.173.7.684"},{"key":"e_1_3_2_568_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2010.03.017"},{"key":"e_1_3_2_569_2","first-page":"265","article-title":"Tuberculosis trends\u2014United States, 2014","volume":"64","author":"Scott C","year":"2015","unstructured":"Scott C , Kirking HL , Jeffries C , Price SF , Pratt R . 2015. Tuberculosis trends\u2014United States, 2014. MMWR Morb Mortal Wkly Rep 64:265\u2013269.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_2_570_2","doi-asserted-by":"publisher","DOI":"10.1093\/milmed\/164.4.289"},{"key":"e_1_3_2_571_2","doi-asserted-by":"publisher","DOI":"10.1093\/milmed\/166.2.116"},{"key":"e_1_3_2_572_2","first-page":"iii","volume-title":"Information about tuberculin skin test (TST) conversion rates for the US Navy and Marine Corps","author":"Tepper M","year":"2007","unstructured":"Tepper M , Anderson J , Crane F , Schofield S , Tsekrekos S . 2007. Information about tuberculin skin test (TST) conversion rates for the US Navy and Marine Corps. Mil Med 172:iii\u2013iv."},{"key":"e_1_3_2_573_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-1-4557-0090-5.00040-9"},{"key":"e_1_3_2_574_2","doi-asserted-by":"publisher","DOI":"10.7205\/MILMED-D-12-00297"},{"key":"e_1_3_2_575_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa031667"},{"key":"e_1_3_2_576_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-443-06839-3.00250-2"},{"key":"e_1_3_2_577_2","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/B978-1-4160-4710-0.00034-1","volume-title":"Textbook of respiratory medicine","author":"Hopewell PC","year":"2010","unstructured":"Hopewell PC , Kato-Maeda M . 2010. Tuberculosis, p 754\u2013792. In Mason RJ , Broaddus VC , Martin TR , King TE , Schraufnagel DE , Murray JF , Nadel JA (ed), Textbook of respiratory medicine, 6th ed. Saunders Elsevier Inc, Philadelphia, PA.","edition":"6"},{"key":"e_1_3_2_578_2","unstructured":"Centers for Disease Control and Prevention. 2013. Core curriculum on tuberculosis: what the clinician should know 6th ed. Centers for Disease Control and Prevention Atlanta GA. http:\/\/www.cdc.gov\/tb\/education\/corecurr\/pdf\/corecurr_all.pdf . Accessed 28 January 2015."},{"key":"e_1_3_2_579_2","first-page":"7","article-title":"Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis","volume":"58","author":"Centers for Disease Control and Prevention","year":"2009","unstructured":"Centers for Disease Control and Prevention. 2009. Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis. MMWR Morb Mortal Wkly Rep 58:7\u201310.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_2_580_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-005-0039-1"},{"key":"e_1_3_2_581_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.161.4.16141"},{"key":"e_1_3_2_582_2","first-page":"1","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection","volume":"49","author":"American Thoracic Society","year":"2000","unstructured":"American Thoracic Society. 2000. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recommend Rep 49:1\u201351.","journal-title":"MMWR Recommend Rep"},{"key":"e_1_3_2_583_2","unstructured":"Assistant Secretary of Defense Health Affairs. 29 September 2008. Policy for the use of Tubersol as the preferred brand of tuberculin (HA Policy 08-012). Department of Defense Washington DC. http:\/\/www.health.mil\/\u223c\/media\/MHS\/Policy%20Files\/Import\/08-012.ashx . Accessed 28 January 2015."},{"key":"e_1_3_2_584_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200802-223OC"},{"key":"e_1_3_2_585_2","unstructured":"Association of Public Health Laboratories. 2013. Fact sheet: Cepheid Xpert MTB\/RIF assay. Association of Public Health Laboratories Silver Spring MD. http:\/\/www.aphl.org\/AboutAPHL\/publications\/Documents\/ID_2013Nov_Cepheid-Xpert-Fact-Sheet.pdf . Accessed 4 March 2015."},{"key":"e_1_3_2_586_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043307"},{"key":"e_1_3_2_587_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001064"},{"key":"e_1_3_2_588_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001061"},{"key":"e_1_3_2_589_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1413930"},{"key":"e_1_3_2_590_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.33.7.1832-1834.1995"},{"key":"e_1_3_2_591_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.9.4307-4309.2004"},{"key":"e_1_3_2_592_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1104875"},{"key":"e_1_3_2_593_2","first-page":"1650","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","unstructured":"Centers for Disease Control and Prevention. 2011. Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection. MMWR Morb Mortal Wkly Rep 60:1650\u20131653.","journal-title":"Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection"},{"key":"e_1_3_2_594_2","volume-title":"Treatment of tuberculosis guidelines","author":"World Health Organization","year":"2010","unstructured":"World Health Organization. 2010. Treatment of tuberculosis guidelines, 4th ed. World Health Organization, Geneva, Switzerland.","edition":"4"},{"key":"e_1_3_2_595_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1407426"},{"key":"e_1_3_2_596_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe1410977"},{"key":"e_1_3_2_597_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1314210"},{"key":"e_1_3_2_598_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1315817"},{"key":"e_1_3_2_599_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1314385"},{"key":"e_1_3_2_600_2","first-page":"1","article-title":"Provisional CDC guidelines for the use and safety monitoring of bedaquiline fumarate (Sirturo) for the treatment of multidrug-resistant tuberculosis","volume":"62","author":"Mase S","year":"2013","unstructured":"Mase S , Chorba T , Lobue P , Castro K . 2013. Provisional CDC guidelines for the use and safety monitoring of bedaquiline fumarate (Sirturo) for the treatment of multidrug-resistant tuberculosis. MMWR Recommend Rep 62:1\u201312.","journal-title":"MMWR Recommend Rep"},{"key":"e_1_3_2_601_2","unstructured":"Mase S . 31 March 2014. CDC expert commentary: new drug available to treat multidrug-resistant tuberculosis. MedScape. Accessed 8 April 2014. http:\/\/www.medscape.com\/viewarticle\/822098 ."},{"key":"e_1_3_2_602_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70328-1"},{"key":"e_1_3_2_603_2","first-page":"1","article-title":"Treatment of tuberculosis","volume":"52","author":"American Thoracic Society, Centers for Disease Control and Prevention, Infectious Diseases Society of America","year":"2003","unstructured":"American Thoracic Society, Centers for Disease Control and Prevention, Infectious Diseases Society of America. 2003. Treatment of tuberculosis. MMWR Recommend Rep 52:1\u201377.","journal-title":"MMWR Recommend Rep"},{"key":"e_1_3_2_604_2","first-page":"1","article-title":"Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005","volume":"54","author":"Jensen PA","year":"2005","unstructured":"Jensen PA , Lambert LA , Iademarco MF , Ridzon R . 2005. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recommend Rep 54:1\u2013141.","journal-title":"MMWR Recommend Rep"},{"key":"e_1_3_2_605_2","doi-asserted-by":"publisher","DOI":"10.1016\/0962-8479(92)90129-8"},{"key":"e_1_3_2_606_2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1128\/9781555818357","volume-title":"Tuberculosis: pathogenesis, protection, and control","author":"Bloom BR","year":"1994","unstructured":"Bloom BR , Fine PEM . 1994. The BCG experience: implications for future vaccines against tuberculosis, p 531\u2013557. In Bloom BR (ed), Tuberculosis: pathogenesis, protection, and control. ASM Press, Washington, DC."},{"key":"e_1_3_2_607_2","unstructured":"Centers for Disease Control and Prevention. 1 September 2012. Tuberculosis fact sheet. Centers for Disease Control and Prevention Atlanta GA. http:\/\/www.cdc.gov\/tb\/publications\/factsheets\/testing\/igra.htm . Accessed 28 January 2015."},{"key":"e_1_3_2_608_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)62173-3"},{"key":"e_1_3_2_609_2","doi-asserted-by":"publisher","DOI":"10.7205\/MILMED-D-14-00433"},{"key":"e_1_3_2_610_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1708-8305.2010.00424.x"},{"key":"e_1_3_2_611_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe1111859"},{"key":"e_1_3_2_612_2","article-title":"Acute respiratory disease syndrome (ARDS) reportub","author":"US Army Public Health Command","year":"2015","unstructured":"US Army Public Health Command. 31 January 2015. Acute respiratory disease syndrome (ARDS) reportub. US Army Public Health Command, Aberdeen, MD. http:\/\/phc.amedd.army.mil\/whatsnew\/Pages\/PublicationDetails.aspx?type=USAPHC%20ARDS%20Report . Accessed 11 February 2015.","journal-title":"US Army Public Health Command, Aberdeen, MD"},{"key":"e_1_3_2_613_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.04.035"},{"key":"e_1_3_2_614_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1304.061308"},{"key":"e_1_3_2_615_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir282"},{"key":"e_1_3_2_616_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034581"},{"key":"e_1_3_2_617_2","first-page":"947","article-title":"Influenza outbreak in a vaccinated population\u2014USS Ardent, February 2014","volume":"63","author":"Aquino TL","year":"2014","unstructured":"Aquino TL , Brice GT , Hayes S , Myers CA , McDowell J , White B , Garten R , Johnston D . 2014. Influenza outbreak in a vaccinated population\u2014USS Ardent, February 2014. MMWR Morb Mortal Wkly Rep 63:947\u2013949.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_2_618_2","doi-asserted-by":"publisher","DOI":"10.1093\/milmed\/165.suppl_2.52"},{"key":"e_1_3_2_619_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2009.04.022"},{"key":"e_1_3_2_620_2","unstructured":"US Air Force School of Aerospace Medicine. 28 October 2014. DoD global laboratory-based influenza surveillance program report weeks 41 & 42. US Air Force School of Aerospace Medicine Wright-Patterson Air Force Base OH. http:\/\/afhsc.army.mil\/documents\/pubs\/USAFSAM_Flu_Reports\/2014-2015\/2014-10-18_DoD_Global%20Laboratory-based%20Influenza_Surveillance_Report_42.pdf . Accessed 28 October 2014."},{"key":"e_1_3_2_621_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.01.022"},{"key":"e_1_3_2_622_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-2659.2010.00129.x"},{"issue":"6","key":"e_1_3_2_623_2","first-page":"15","article-title":"Brief report: mid-season influenza vaccine effectiveness estimates for the 2013-2014 influenza season","volume":"21","author":"Cost AA","year":"2014","unstructured":"Cost AA , Hiser MJ , Hu Z , Cooper MJ , Hawksworth AW , Radin JM , Brice GT , Zorich SC , DeMarcus LS , Tastad KJ , Sanchez JL . 2014. Brief report: mid-season influenza vaccine effectiveness estimates for the 2013-2014 influenza season. MSMR 21(6):15\u201317.","journal-title":"MSMR"},{"key":"e_1_3_2_624_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.03.088"},{"issue":"3","key":"e_1_3_2_625_2","first-page":"15","article-title":"Mid-season influenza vaccine effectiveness for the 2012-2013 influenza season","volume":"20","author":"Eick-Cost AA","year":"2013","unstructured":"Eick-Cost AA , Hu Z , Cooper MJ , Sanchez JL , Radin JM , Hawksworth AW , Brice GT , Lloyd LV , Tastad KJ , Zorich SC , MacIntosh VH . 2013. Mid-season influenza vaccine effectiveness for the 2012-2013 influenza season. MSMR 20(3):15\u201316.","journal-title":"MSMR"},{"key":"e_1_3_2_626_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010722"},{"key":"e_1_3_2_627_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.265"},{"key":"e_1_3_2_628_2","first-page":"394","article-title":"Immunization with types 4 and 7 adenovirus by selective infection of the intestinal tract","volume":"88","author":"Couch RB","year":"1963","unstructured":"Couch RB , Chanock RM , Cate TR , Lang DJ , Knight V , Huebner RJ . 1963. Immunization with types 4 and 7 adenovirus by selective infection of the intestinal tract. Am Rev Respir Dis 88(Suppl):394\u2013403.","journal-title":"Am Rev Respir Dis"},{"key":"e_1_3_2_629_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1966.03100060093026"},{"key":"e_1_3_2_630_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/124.2.148"},{"key":"e_1_3_2_631_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/124.2.155"},{"key":"e_1_3_2_632_2","unstructured":"Military Vaccine Agency Vaccine Healthcare Centers Network. 25 April 2012. Impact of adenovirus vaccine reintroduction at military accession sites 25 April 2012. Military Vaccine Agency Falls Church VA. http:\/\/www.vaccines.mil\/Adenovirus . Accessed 28 October 2014."},{"key":"e_1_3_2_633_2","unstructured":"Pueschel M . 14 April 2011. New vaccine should reduce respiratory illnesses in recruits. Force Health Protection and Readiness Falls Church VA. http:\/\/home.fhpr.osd.mil\/press-newsroom\/fhpr-news\/current_news\/11-04-14\/New_Vaccine_Should_Reduce_respiratory_Illnesses_in_Recruits.aspx . Accessed 28 October 2014."},{"key":"e_1_3_2_634_2","unstructured":"Petska A . 30 March 2015. Teva Pharmaceuticals wins $170 million contract to make vaccine in Forest. Roanoke Times Roanoke VA. http:\/\/www.roanoke.com\/business\/news\/teva-pharmaceuticals-wins-million-contract-to-make-vaccine-in-forest\/article_285867bf-a41f-5d6e-941f-e3467c62a492.html . Accessed 8 April 2015."},{"key":"e_1_3_2_635_2","doi-asserted-by":"publisher","DOI":"10.1128\/genomeA.00324-14"},{"key":"e_1_3_2_636_2","unstructured":"Pellerin C . 12 May 2014. DOD lab identified first cases of Middle East coronavirus. US Department of Defense Washington DC. http:\/\/www.defense.gov\/news\/newsarticle.aspx?id=122231 . Accessed 13 May 2014."},{"key":"e_1_3_2_637_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02533-13"},{"key":"e_1_3_2_638_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1201.051214"},{"key":"e_1_3_2_639_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1509.090702"},{"key":"e_1_3_2_640_2","doi-asserted-by":"publisher","DOI":"10.7205\/MILMED-D-10-00166"},{"key":"e_1_3_2_641_2","doi-asserted-by":"publisher","DOI":"10.7205\/MILMED-D-13-00406"},{"key":"e_1_3_2_642_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1003064"},{"key":"e_1_3_2_643_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39393.510347.BE"},{"key":"e_1_3_2_644_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b3675"},{"key":"e_1_3_2_645_2","doi-asserted-by":"publisher","DOI":"10.1017\/S095026881400003X"},{"key":"e_1_3_2_646_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032867"},{"key":"e_1_3_2_647_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit797"},{"key":"e_1_3_2_648_2","first-page":"1","article-title":"Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, 1994","volume":"43","author":"Centers for Disease Control and Prevention","year":"1994","unstructured":"Centers for Disease Control and Prevention. 1994. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, 1994. MMWR Recommend Rep 43:1\u2013132.","journal-title":"MMWR Recommend Rep"},{"key":"e_1_3_2_649_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2004.12.010"},{"key":"e_1_3_2_650_2","unstructured":"Gibson RL . 1997. Primary prevention of acute respiratory infection among United States Air Force recruits through the use of antimicrobial handwipes\u2014a randomized clinical trial. Report 96-47D. Department of the Air Force Wright-Patterson Air Force Base OH. https:\/\/digital.lib.washington.edu\/researchworks\/handle\/1773\/10905 . Accessed 28 January 2015."},{"key":"e_1_3_2_651_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2007.124610"},{"key":"e_1_3_2_652_2","doi-asserted-by":"publisher","DOI":"10.1086\/595845"},{"key":"e_1_3_2_653_2","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12324"},{"key":"e_1_3_2_654_2","doi-asserted-by":"publisher","DOI":"10.1086\/656581"},{"key":"e_1_3_2_655_2","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12204"},{"key":"e_1_3_2_656_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1704.101353"},{"key":"e_1_3_2_657_2","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3182218656"},{"key":"e_1_3_2_658_2","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12015"},{"key":"e_1_3_2_659_2","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181b9e8b3"},{"key":"e_1_3_2_660_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.1466"},{"key":"e_1_3_2_661_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp0908437"},{"key":"e_1_3_2_662_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2005.08.018"},{"key":"e_1_3_2_663_2","doi-asserted-by":"publisher","DOI":"10.1080\/15459620600829211"},{"key":"e_1_3_2_664_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201303-0581ED"},{"key":"e_1_3_2_665_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-2659.2011.00205.x"},{"key":"e_1_3_2_666_2","doi-asserted-by":"publisher","DOI":"10.1177\/003335491012500206"},{"key":"e_1_3_2_667_2","doi-asserted-by":"publisher","DOI":"10.1086\/650396"},{"key":"e_1_3_2_668_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1502.081167"},{"key":"e_1_3_2_669_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002101"},{"key":"e_1_3_2_670_2","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-6-216"},{"key":"e_1_3_2_671_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-2659.2011.00307.x"},{"key":"e_1_3_2_672_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-2659.2011.00198.x"},{"key":"e_1_3_2_673_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201207-1164OC"},{"key":"e_1_3_2_674_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2014.01.015"},{"key":"e_1_3_2_675_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-2659.2011.00237.x"},{"key":"e_1_3_2_676_2","doi-asserted-by":"publisher","DOI":"10.2307\/30142367"},{"key":"e_1_3_2_677_2","first-page":"87","article-title":"Report of an epidemic of \u201cSpanish influenza\u201d which occurred at Camp A.A","volume":"4","author":"Brewer IW","year":"1918","unstructured":"Brewer IW . 1918. Report of an epidemic of \u201cSpanish influenza\u201d which occurred at Camp A.A. Humphreys, VA, during September and October 1918. J Lab Clin Med 4:87.","journal-title":"Humphreys, VA, during September and October 1918. J Lab Clin Med"},{"key":"e_1_3_2_678_2","first-page":"418","article-title":"United States Army guidelines for troop living space: a historical review","volume":"145","author":"Brodkey C","year":"1980","unstructured":"Brodkey C , Gaydos JC . 1980. United States Army guidelines for troop living space: a historical review. Mil Med 145:418\u2013421.","journal-title":"Mil Med"},{"key":"e_1_3_2_679_2","first-page":"328","article-title":"Patterns of adenovirus infections in Marine Corps personnel. I. A 42-month survey in recruit and nonrecruit populations","volume":"80","author":"Bloom HH","year":"1964","unstructured":"Bloom HH , Forsyth BR , Johnson KM , Mufson MA , Turner HC , Davidson MA , Chanock RM . 1964. Patterns of adenovirus infections in Marine Corps personnel. I. A 42-month survey in recruit and nonrecruit populations. Am J Hyg (Lond) 80:328\u2013342.","journal-title":"Am J Hyg (Lond)"},{"key":"e_1_3_2_680_2","unstructured":"Sanchez JL Binn LN Innis BL Craig SC Reynolds RD Lee T Marquez JP Mitchell-Raymundo F Shepherd GA Polyak CS . 1999. Epidemiologic consultation no. 29-HE-8062-97. Investigation of adenovirus and acute respiratory disease epidemic among recruits Fort Jackson South Carolina November-December 1997 (USACHPPM EPICON final report). U.S. Army Center for Health Promotion and Preventive Medicine Aberdeen MD. http:\/\/www.dtic.mil\/cgi-bin\/GetTRDoc?AD=ADA371015 . Accessed 28 January 2015."},{"key":"e_1_3_2_681_2","first-page":"67","volume-title":"Armed Forces Epidemiological Board, the histories of the commissions, textbook of military medicine","author":"Jordan WS","year":"1994","unstructured":"Jordan WS . 1994. History of the Commission of Acute Respiratory Diseases, Commission on Air-Borne Infections, Commission on Meningococcal Meningitis, and Commission on Pneumonia, p 67\u201371. In Woodward TE (ed), Armed Forces Epidemiological Board, the histories of the commissions, textbook of military medicine, vol 1. Office of the Surgeon General, Borden Institute, Walter Reed Army Medical Center, Washington, DC."},{"key":"e_1_3_2_682_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.35.5.457"},{"key":"e_1_3_2_683_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.37.5.529"},{"key":"e_1_3_2_684_2","first-page":"227","article-title":"Studies of the control of acute respiratory diseases among naval recruits; a review of a 4-year experience with ultraviolet irradiation and dust suppressive measures, 1943 to 1947","volume":"48","author":"Willmon TL","year":"1948","unstructured":"Willmon TL , Hollander A , Langmuir AD . 1948. Studies of the control of acute respiratory diseases among naval recruits; a review of a 4-year experience with ultraviolet irradiation and dust suppressive measures, 1943 to 1947. Am J Hyg (Lond) 48:227\u2013232.","journal-title":"Am J Hyg (Lond)"},{"key":"e_1_3_2_685_2","first-page":"240","article-title":"Studies of the control of acute respiratory diseases among naval recruits; the epidemiological pattern and the effect of ultraviolet irradiation during the winter of 1946-1947","volume":"48","author":"Langmuir AD","year":"1948","unstructured":"Langmuir AD , Jarrett RT , Hollaender A . 1948. Studies of the control of acute respiratory diseases among naval recruits; the epidemiological pattern and the effect of ultraviolet irradiation during the winter of 1946-1947. Am J Hyg (Lond) 48:240\u2013251.","journal-title":"Am J Hyg (Lond)"},{"key":"e_1_3_2_686_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051653"},{"key":"e_1_3_2_687_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-13-811"},{"key":"e_1_3_2_688_2","unstructured":"European Center for Disease Prevention and Control. 19 May 2009. Personal protective measures for reducing the risk of acquiring or transmitting human influenza. European Center for Disease Prevention and Control Solna Sweden. http:\/\/ecdc.europa.eu\/en\/healthtopics\/Documents\/0905_InfluenzaAH1N1_Personal_protective_measures.pdf . Accessed 12 November 2014."},{"key":"e_1_3_2_689_2","volume-title":"Non-vaccine recommendations to prevent acute infectious respiratory disease among U.S. Army personnel living in close quarters. Technical guide 314","author":"Bowman S","year":"2007","unstructured":"Bowman S . 2007. Non-vaccine recommendations to prevent acute infectious respiratory disease among U.S. Army personnel living in close quarters. Technical guide 314. US Army Center for Health Promotion and Preventive Medicine, Aberdeen, MD. https:\/\/www.vaccines.mil\/documents\/1069TG314.pdf ."},{"key":"e_1_3_2_690_2","first-page":"285","article-title":"Nonpharmaceutical interventions for military populations during pandemic influenza","volume":"6","author":"Kilic S","year":"2007","unstructured":"Kilic S , Gray GC . 2007. Nonpharmaceutical interventions for military populations during pandemic influenza. Turk Silahli Kuvvetleri Koruyucu Hekim Bul 6:285\u2013290.","journal-title":"Turk Silahli Kuvvetleri Koruyucu Hekim Bul"},{"key":"e_1_3_2_691_2","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12080"},{"key":"e_1_3_2_692_2","volume-title":"America's forgotten pandemic: the influenza of 1918","author":"Crosby AW","year":"1989","unstructured":"Crosby AW . 1989. America's forgotten pandemic: the influenza of 1918. Cambridge University Press, Cambridge, United Kingdom."},{"key":"e_1_3_2_693_2","volume-title":"The Armed Forces Epidemiological Board: its first fifty years","author":"Woodward TE","year":"1990","unstructured":"Woodward TE , Center of Excellence in Military Medical Research and Education. 1990. The Armed Forces Epidemiological Board: its first fifty years. Office of the Surgeon General, Department of the Army, Falls Church, VA."},{"key":"e_1_3_2_694_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(69)80299-4"},{"key":"e_1_3_2_695_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a120903"},{"key":"e_1_3_2_696_2","doi-asserted-by":"publisher","DOI":"10.1002\/9781118543504.ch16"},{"key":"e_1_3_2_697_2","doi-asserted-by":"publisher","DOI":"10.1186\/2054-9369-1-21"},{"key":"e_1_3_2_698_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-11-S2-S2"},{"key":"e_1_3_2_699_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-11-S2-S6"},{"issue":"4","key":"e_1_3_2_700_2","first-page":"26","article-title":"Surveillance snapshot: illness and injury burdens among U.S. military recruit trainees, 2014","volume":"20","author":"Armed Forces Health Surveillance Center","year":"2015","unstructured":"Armed Forces Health Surveillance Center. 2015. Surveillance snapshot: illness and injury burdens among U.S. military recruit trainees, 2014. Med Surveill Monthly Rep 20(4):26.","journal-title":"Med Surveill Monthly Rep"},{"issue":"4","key":"e_1_3_2_701_2","first-page":"5","article-title":"Absolute and relative morbidity burdens attributable to various illnesses and injuries, U.S. Armed Forces, 2014","volume":"22","author":"Armed Forces Health Surveillance Center","year":"2015","unstructured":"Armed Forces Health Surveillance Center. 2015. Absolute and relative morbidity burdens attributable to various illnesses and injuries, U.S. Armed Forces, 2014. Med Surveill Monthly Rep 22(4):5\u201310.","journal-title":"Med Surveill Monthly Rep"},{"key":"e_1_3_2_702_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu399"},{"key":"e_1_3_2_703_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ345"},{"key":"e_1_3_2_704_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2105.141137"},{"key":"e_1_3_2_705_2","volume-title":"Influenza (flu), situation update: summary of weekly FluView","author":"Centers for Disease Control and Prevention","year":"2015","unstructured":"Centers for Disease Control and Prevention. 8 May 2015, posting date. Influenza (flu), situation update: summary of weekly FluView. Centers for Disease Control and Prevention, Atlanta, GA. http:\/\/www.cdc.gov\/flu\/weekly\/summary.htm . Accessed 13 May 2015."},{"key":"e_1_3_2_706_2","author":"Centers for Disease Control and Prevention","year":"2014","unstructured":"Centers for Disease Control and Prevention. 19 August, 2014, posting date. Influenza (flu), information on swine influenza\/variant influenza viruses. Centers for Disease Control and Prevention, Atlanta, GA. http:\/\/www.cdc.gov\/flu\/swineflu\/index.htm . Accessed 13 May 2015.","journal-title":"Influenza (flu), information on swine influenza\/variant influenza viruses"},{"key":"e_1_3_2_707_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv109"},{"key":"e_1_3_2_708_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-0806-2"},{"key":"e_1_3_2_709_2","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12313"},{"key":"e_1_3_2_710_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201312-2235OC"},{"key":"e_1_3_2_711_2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.7883\/yoken.JJID.2007.97","article-title":"PCR and serology were effective for identifying Chlamydophila pneumoniae in a lower respiratory infection outbreak among military recruits","volume":"60","author":"Oktem IM","year":"2007","unstructured":"Oktem IM , Ellidokuz H , Sevinc C , Kilinc O , Aksakoglu G , Sayiner A , Ucan ES , Sezqin S , Ozdemir H , Yuksel B . 2007. PCR and serology were effective for identifying Chlamydophila pneumoniae in a lower respiratory infection outbreak among military recruits. Jpn J Infect Dis 60:97\u2013101.","journal-title":"Jpn J Infect Dis"},{"key":"e_1_3_2_712_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2106.141394"},{"key":"e_1_3_2_713_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-0746-x"},{"key":"e_1_3_2_714_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1405427"},{"key":"e_1_3_2_715_2","doi-asserted-by":"publisher","DOI":"10.1111\/resp.12541"},{"key":"e_1_3_2_716_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h694"},{"key":"e_1_3_2_717_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-006577"},{"key":"e_1_3_2_718_2","author":"Center for Infectious Disease Research and Policy","unstructured":"Center for Infectious Disease Research and Policy. 1 June 2015, posting date. Korean MERS total surges to 25 cases, 2 deaths. Center for Infectious Disease Research and Policy, Minneapolis, MN. http:\/\/www.cidrap.umn.edu\/news-perspective\/2015\/06\/korean-mers-total-surges-25-cases-2-deaths . Accessed 2 June 2015.","journal-title":"Korean MERS total surges to 25 cases, 2 deaths"}],"container-title":["Clinical Microbiology Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CMR.00039-14","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CMR.00039-14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T15:33:34Z","timestamp":1717947214000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CMR.00039-14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":717,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["10.1128\/CMR.00039-14"],"URL":"https:\/\/doi.org\/10.1128\/cmr.00039-14","relation":{},"ISSN":["0893-8512","1098-6618"],"issn-type":[{"value":"0893-8512","type":"print"},{"value":"1098-6618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"2015-06-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}